In Brain & Behavioral Health Research
Below is a listing extramural funding opportunities compiled by BBHI. Updated monthly.
Download Current BBH Funding Opportunities Here
Last updated on September 15, 2021
Biologic-based Drug Discovery and Development for Disorders of the Nervous System
PAR-21-163 (UG3/UH3 Clinical Trial Optional)
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This FOA supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies).
Small Molecule Drug Discovery and Development of Disorders of the Nervous System
PAR-20-122 (UG3/UH3 Clinical Trial Optional)
BPN invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories.
Deadline: 09 Feb 2022
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The total duration of both the UG3 and UH3 cannot exceed 5 years.
Keywords: Biotechnology, Biotherapy, Gene Therapy, Microbial Processes, Microbiology, Chemical Synthesis, Drug Design, Neurological Disorders, Neuroscience, Pharmaceuticals, Pharmacokinetics, Toxicology
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain
RFA-NS-19-001 (U01 Clinical Trial Required)
This RFA seeks applications to assemble diverse, integrated, multi-disciplinary teams that cross boundaries of interdisciplinary collaboration to overcome these fundamental barriers and to investigate high-impact questions in human neuroscience. Projects should maximize opportunities to conduct innovative in vivo neuroscience research made available by direct access to brain recording and stimulating from invasive surgical procedures. Projects should employ approaches guided by specified theoretical constructs and quantitative, mechanistic models where appropriate.
Deadline: September 29, 2021 (LOI) ; October 29, 2021 (Application)
Amount: Estimated total of $8M to fund 5 awards per receipt date. The maximum project period is 5 years.
Keywords: Brain Data Management or Analysis (Medical); Nervous System; Neuroscience; Surgery & Intensive Care
* * * * *
Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System
RFA-NS-21-024 (UH3 Clinical Trial Required)
This FOA encourages investigators to pursue first-in-human or early stage clinical studies for recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain. Only Significant Risk studies that require an Investigational Device Exemption from the FDA, such as chronic implants, will be supported by this FOA. The clinical study is expected to provide data to answer key questions about the function or final design of a device and is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use.
Deadlnes: 20 Oct 2021, 18 Feb 2022, 20 Jun 2022, 18 Oct 2022 (Confirmed)
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. Budgets should rarely exceed $1,500,000. The total duration may not exceed 5 years.
Keywords: Brain Data Collection, Data Management or Analysis (Medical), Medical Device Engineering, Medical Devices, Nervous System
* * * * *
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain
RFA-MH-19-136 (R01 Clinical Trial Not Allowed)
BRAIN Initiative encourages researchers to develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new genetic and non-genetic tools for delivering genes, proteins and chemicals to cells of interest or approaches that are expected to target specific cell types and/or circuits in the nervous system with greater precision and sensitivity than currently established methods are encouraged. Tools that can be used in a number of species/model organisms rather than those restricted to a single species are highly desired. Applications that provide approaches that break through existing technical barriers to substantially improve current capabilities are highly encouraged.
Deadline(s): 08 Oct 2021, 07 Oct 2022, 06 Oct 2023 (Confirmed)
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 3 years.
Keywords: Biochemistry, Proteins, Brain, Genetics, Molecular Cellular Entities
* * * * *
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System
RFA-EY-18-001 (R21 Clinical Trial Not Allowed)
This Initiative seeks applications for unique and innovative recording and/or modulation technologies that are in the earliest stage of development, including new and untested ideas that are in the initial stages of conceptualization. Some projects may aim to increase recording or modulation capabilities by many orders of magnitude, while others may aim to improve the precision and selectivity of recording or modulation (also referred to as stimulation, perturbation, or manipulation). A wide range of modalities are appropriate including acoustic, chemical, electrical, magnetic, optical and chemical, as well as the use of genetic tools. Invasive or non-invasive approaches are sought that will enable large-scale recording and/or precise manipulation of neural activity, and that would ultimately be compatible with experiments in humans or behaving animals. Applications are encouraged from any qualified individuals, including physicists, engineers, theoreticians, and scientists, especially those not typically involved with neuroscience research.
Deadlines: 29 Oct 2021, 02 May 2022, 28 Oct 2022, 01 May 2023 (Confirmed)
Amount: Application budgets may not exceed $400,000 (total direct costs) over a maximum three-year funding period. No more than $200,000 (total direct costs) may be requested in any single year. The maximum project period is 3 years.
Keywords: Biological Modeling, Biomedical Research (Multidisciplinary), Computational Neuroscience, Mathematical Modeling (Medical), Medical Technology, Neural Stimulation, Neuroanatomy, Neurobiology, Neuroethology, Neurology, Neurophysiology, Neuroscience
* * * * *
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System
RFA-NS-21-026 (R01 Clinical Trial Not Allowed)
Understanding the dynamic activity of brain circuits is central to the NIH BRAIN Initiative. BRAIN seeks applications for proof-of-concept testing and development of new technologies and novel approaches for recording and modulation (including various modalities for stimulation/activation, inhibition and manipulation) of cells (i.e., neuronal and non-neuronal) and networks to enable transformative understanding of dynamic signaling in the central nervous system (CNS). This FOA seeks exceptionally creative approaches to address major challenges associated with recording and modulating CNS activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain. It is expected that the proposed research may be high-risk, but if successful, could profoundly change the course of neuroscience research. ...If suitable, applications are expected to integrate appropriate domains of expertise, including biological, chemical and physical sciences, engineering, computational modeling and statistical analysis.
Deadlines: 29 Oct 2021, 02 May 2022, 28 Oct 2022, 01 May 2023
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 3 years.
Keywords: Brain, Medical Technology, Nervous System, Neural Stimulation, Radiology & Medical Imaging
* * * * *
Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System
RFA-NS-21-023 (UG3/UH3 Clinical Trial Optional)
This initiative seeks investigators to pursue translational activities and small clinical studies for recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption for a Significant Risk study, as well as a subsequent small clinical study... The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. Individuals, institutions, or businesses developing their own devices or that already have established collaborations with device manufacturers are welcome to apply.
Deadlines: 20 Oct 2021, 18 Feb 2022, 20 Jun 2022
Amount: Applicants should rarely exceed $1,000,000 direct costs per year for the UG3 phase and $1,500,000 direct costs per year for the UH3 phase. The total duration of the UG3 and UH3 may not exceed 5 years.
Keywords: Applied Sciences, Brain, Clinical Research or Studies, Health and Medicine, Medical Device Engineering, Medical Devices, Nervous System, Neural Stimulation, Neurobiology, Neurological Disorders, Neurology, Neuroscience, Technology Assessment or Transfer (Medical)
* * * * *
Eligibility: Higher Education Institutions,Nonprofits Other Than Institutions of Higher Education, For-Profit Organizations*, Governments, Other: Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations, Faith-based or Community-based Organizations, Regional Organizations.
https://braininitiative.nih.gov/funding/funding-opportunities
HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics]
RFA-NS-21-015 (U19 Clinical Trial Not Allowed)
This funding opportunity announcement (FOA) is part of a suite of FOAs to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal of this FOA is to support team-based research projects to develop assays, screening and early optimization work to develop a non-addictive therapeutic to treat pain. Discovery and validation of pharmacodynamic markers efficacy and pharmacokinetic/pharmacodynamic (PK/PD) studies are also responsive. The result of the project should be to advance a hit or lead to the point where they can meet the entry criteria for RFA-NS-21-010 HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) within the 5 years of the award, there is no opportunity for renewal of this award.
Deadlines: 13 Oct 2021, 27 Apr 2022, 09 Jun 2022, 11 Oct 2022. Optional Letter of Intent due 30 days prior to the application due date This call is repeated once a year.
Amount: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. NIH intends to fund an estimate of 3-6 awards, for fiscal year 2021. Future year amounts will depend on annual appropriations. Application budgets are limited to direct costs of $1.5 million per year including all consortium and subaward costs. Award Project Period: 5 years
Keywords: Data Collection, Data Management or Analysis (Medical), Hospice & Palliative Care, Pain, Pharmacokinetics, Pharmacotherapy, Proteins and Macromolecules
* * * * *
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management
RFA-NS-20-008 (R41/R42 Clinical Trial Required)
RFA-NS-20-009 (R41/R42 Clinical Trial Not Allowed)
RFA-NS-20-010 (R43/R44 - Clinical Trial Required)
RFA-NS-20-011 (R43/R44 - Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.
Deadlines: 06 Jan 2022, 06 Apr 2022, 08 Sep 2022. Optional LOI due 30 days prior. This call is repeated once a year.
Amount: Multiple options. Please see RFA.
Eligibility: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
Keywords: Hospice & Palliative Care, Pain
* * * * *
HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief
RFA-NS-22-016 (RM1 Clinical Trial Optional)
This funding opportunity announcement (FOA) is designed to support interdisciplinary research teams of multiple PD/PIs to investigate the mechanism of action of device-based pain relief with the overall goal of optimizing therapeutic outcomes for FDA-approved or -cleared technologies. Teams must leverage appropriate multi-disciplinary expertise to develop new principles and methods for experimentation, analysis, and interpretation. Teams are encouraged to consider objectives that will produce major advances in the understanding of device-based pain relief.
Deadlines: 03 Nov 2021, Optional LOI due 30 days prior. This call may not be repeated.
Amount: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. NIH intends to fund an estimate of 3 awards for fiscal year 2022. Future year amounts will depend on annual appropriations. Application budgets are not limited, but should be consistent with the number of PDs/PIs and the complexity and needs of the proposed program. Application budgets should rarely exceed $1,500,000 direct costs per year. Annual inflationary increases are not allowed. Applications may request up to five years of support.
Keywords: Chronic Pain, Pain
* * * * *
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose
RFA-DA-22-031 (R01 Clinical Trial Not Allowed)
RFA-DA-22-032 (R21 Clinical Trial Not Allowed)
This initiative supports research projects focusing on the identification of druggable new targets and discovery of optimizable probes for development of safe and efficacious medications to prevent and treat opioid use disorders, opioid overdose, and opioid-polysubstance use comorbidities. This FOA is part of the NIH Helping to End Addictions Long-term (HEAL) initiative to accelerate the development of novel medications to treat all aspects of the opioid addiction cycle, including progression to chronic use, withdrawal symptoms, craving, relapse, and overdose. https://heal.nih.gov/research/medication-options
Deadlines: 13 Sep 2021, 19 Oct 2021 (Confirmed); 13 Sep 2022, 19 Oct 2021 (Anticipated)
Amount: $200,000 - 400,000 USD, project period 2-5 years
Keywords: Addictions, Comorbidity, Opioids, Substance Abuse, Substance Abuse Preventi
* * * * *
Eligibility: (Unless specificied): Academic Institution, Commercial or Private Sector, Government or Public Sector, Individuals: Early Career and Emerging in Field, Individuals: Mid-Career to Established in Field, Non-profit,Small Business only
NCMRR Early Career Research Award
PAR-20-042 (R03 Clinical Trial Optional)
NIH-NCMRR invites applications to support both basic and clinical research from rehabilitation scientists who are establishing independent research careers. The research must be focused on one or more of the areas within the biomedical and behavioral mission of NCMRR: pathophysiology and management of chronically injured nervous and musculoskeletal systems (including stroke, traumatic brain injury, spinal cord injury, and orthopedic conditions); repair and recovery of motor and cognitive function; functional plasticity, adaptation, and windows of opportunity for rehabilitative interventions; rehabilitative strategies involving pharmaceutical, stimulation, and neuroengineering approaches, exercise, motor training, and behavioral modifications; pediatric rehabilitation; secondary conditions associated with chronic disabilities; improved diagnosis, assessment, and outcome measures; and development of orthotics, prosthetics, and other assistive technologies and devices.
Deadline: March 30, 2022 (applications accepted annually)
Amount: $200,000 USD, 2-years
Keywords: Biomedical Research (Multidisciplinary), Clinical Research or Studies Musculoskeletal System, Physical Medicine and Rehabilitation
NICHD Research Education Programs
PAR-19-212 (R25 Clinical Trial Optional)
The NIH Research Education Program supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this program will support creative educational activities with a primary focus on courses for Skills Development.
Deadlines: 25 Sep 2021, 25 Jan 2022, 25 May 2022. Optional LOIs are due 30 days prior. This is a one-off opportunity. We do not expect future rounds.
Amount: Application budgets must reflect the actual needs of the proposed project, and are limited to $150,000 direct costs per year. The scope of the proposed project should determine the project period. The maximum project period is 5 years
Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit, Small Business only
Keywords: Behavioral Biology, Behavioral Medicine, Behavioral Pharmacology, Behavioral Problems or Disorders, Behavioral Science Education, Behavioral Therapy, Biomedical Engineering, Biomedical Research (Multidisciplinary), Biomedical Research Resources, Biomedical Research Resources, Biomedical Research Training, Cell & Developmental Biology, Child or Maternal Health, Family MedicineHuman Development, Neonatology, Public Health, Reproductive Health Services
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research. (R03 Clinical Trial Not Allowed)
Area of Focus Archiving and Leveraging Existing Data Sets for Analyses. PAS-19-391
Area of Focus Basic Science PAS-19-392
Area of Focus Systems Biology PAS-19-393
This Small Research Grant Program will support important and innovative projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Specifically, this FOA will support archiving and leveraging existing data sets for analyses of projects covering a wide array of topics relating to AD/ADRD. The overall goal of this FOA is (i) to encourage the next generation of U.S. researchers to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise. Individuals from underrepresented racial and ethnic groups, as well as individuals with disabilities, are always encouraged to apply for NIH support.
Deadlines: 16 Oct 2021, 16 Feb 2022. This call is repeated once a year.
Amount: Applications may request budgets of up to $100,000 in direct costs per year for up to two years. The scope of the project should determine the project period. The maximum project period is 2 years.
Keywords: Alzheimers Disease, Dementia
* * * * *
NIA Academic Leadership Career Award
PAR-21-106 (K07 Independent Clinical Trial Not Allowed)
The objective of the NIA Academic Leadership Career Award (K07) is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by another investigator.
Deadlines: 12 Oct 2021, 12 Feb 2022. This call is repeated once a year.
Amount: NIH will contribute up to $75,000per year toward the salary of the career award recipient. Total direct costs for the salary of the career award recipient and the research coordinator may not exceed $100,000, inclusive of fringe benefits (based on the sponsoring institution's rate) and the percent of effort contributed.
Keywords: Aging, Geriatrics & Gerontology
* * * * *
NIA Research and Entrepreneurial Development Immersion (REDI) Awards
Entrepreneurial Small Business Transition Award
RFA-AG-22-007 (R43/R44 Clinical Trial Optional)
RFA-AG-22-014 (R41/R42 Clinical Trial Optional)
Small Business Innovation Research (SBIR) Grant fosters the career development of early career scientists with an interest in entrepreneurship by simultaneously supporting their entrepreneurial development and facilitating their transition to industry. This program utilizes the R43/R44 Industry Development Award to provide a small business concern the opportunity to support the hiring and salary of postdoctoral fellows and early stage researchers as Principal Investigators/Program Directors (PIs/PDs) to increase its scientific research staff and support product development. Additionally, a major component of this award is a strong focus on entrepreneurial training, mentoring, and career development of the PD/PI. Postdoctoral fellows and early career researchers with strong research skills and experience in technology discovery that have an interest in growing their entrepreneurial skillset and working in the industry represent optimal PD/PIs for this award.
Deadline: 26 Sep 2021 (LOI, optional), 26 Oct 2021 (Application) This call is repeated once a year.
Amount: According to statutory guidelines, total funding support (direct costs, indirect costs, fee) normally may not exceed $259,613 for Phase I awards and $1,730,751 for Phase II awards (with appropriate justification from the applicant). However, NIH has received a waiver from SBA, as authorized by statute, to exceed $259,613 for Phase I or $1,730,751 for Phase II for specific topics. Durations up to 2 years for Phase I and up to 3 years for Fast-Track may be requested.
Eligibility: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
Keywords: Career Education and Planning, Entrepreneurship, Mentoring Programs, Research & Development--R&DTraining and Development
Entrepreneurship Enhancement Award
RFA-AG-22-003 (R25 Clinical Trial Not Allowed)
Entrepreneurship Enhancement Award promotes the development of entrepreneurial education programs that are designed to broaden the skillset of graduate students and postdocs, as well as early career master's, Ph.D., and Dr.P.H. scientists, in fields relevant to the mission of NIA, including aging and Alzheimer's disease (AD) research. The goal of this program is to prepare trainees for a wide range of career paths, including those that are outside the normal research environment.
Amount: Application budgets should not exceed $150,000 in direct costs per year and need to reflect the actual needs of the proposed project. Applications may request a maximum project period of five years.
Deadline: 04 Sep 2021 (LOI, optional), 04 Oct 2021 (Application). This call is repeated once a year.
Keywords: Career Education and Planning, Clinical Research or Studies, Entrepreneurship, Training and Development
Mentored Entrepreneurial Career Development Award
RFA-AG-22-004 (K01 Clinical Trial Not Allowed)
Mentored Entrepreneurial Career Development Award provides support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence.
Deadline: 29 Sep 2021.This call is repeated once a year.
Amount: Award budgets are composed of salary and other program-related expenses. The total project period may not exceed 5 years.
Keywords: Career Education and Planning, Clinical Research or Studies, Entrepreneurship, Mentoring Programs, Training and Development
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias
PAR-21-112 (T32)
NIH-NIA seeks to enable the development of a diverse, translational research workforce capable of participating and/or leading cross-disciplinary team science programs focused on advancing therapy development for Alzheimer's disease (AD) and AD-related dementias (ADRD). This FOA will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e., basic biology, translational and clinical research, data science and behavioral research). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills in data science, disease biology, and traditional and emerging drug discovery disciplines necessary to conduct rigorous and cutting-edge basic, translational, and clinical research for AD and AD-related dementias.
Deadlines: 27 Sep 2021, 25 May 2022, 26 Sep 2022, 25 May 2023 (Confirmed - Expiration Date: September 26, 2023)
Amount: Application budgets are not limited, but need to reflect the actual needs of the proposed project.
Keywords: Alzheimers Disease, Biomedical Research (Multidisciplinary), Dementia, Drug Design, Pharmaceuticals
* * * * *
Eligibility (Unless specificied): Academic Institution, Commercial or Private Sector
Government or Public Sector, Non-profit, Small Business only
Behavioral & Integrative Treatment Development Program
PAR-19-212 (R01 Clinical Trial Optional)
PAR-19-213 (R34 Clinical Trial Optional)
The purpose of this program is to encourage behavioral intervention development research. Specifically, test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological treatments. Research of interest includes but is not limited to Stage I research, including: (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain
Deadline: 23 Mar 2022. Optional LOIs are due 30 days prior. This is a one-off opportunity. We do not expect future rounds.
Amount: The number of awards is contingent upon NIH appropriations, and the submission of a sufficient number of meritorious applications. See FOA for more information.
Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit, Small Business only
Keywords: Addictions, Behavioral Medicine, Behavioral Pharmacology, Chronic Pain, Clinical Trials, Comorbidity, Drug Abuse Treatment, Health Behavior, HIV Prevention, Medical Technology, Pharmacy & Pharmacology
* * * * *
Imaging - Science Track Award for Research Transition (I/START)
PAR-21-309 (R03- Basic Experimental Studies with Humans Required)
This program encourages Small Research Grant applications to facilitate the entry of investigators to the area of neuroimaging, including both newly independent investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs, to enable the conduct of small "proof of concept" studies. The R03 is intended to support research projects that can be carried out in a short period of time with limited resources.
Deadlines: 16 Oct 2021, 16 Feb 2022. This call is repeated once a year.
Amount: Applicants may request direct costs of up to $150,000 for a period of one year only. The maximum project period is 1 year.
Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit.
Keywords: Neuroimaging
* * * * *
Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain
RFA-DA-22-011 (R01 - Clinical Trial Not Allowed)
This opportunity aims to support research that employs innovative scalable technologies to identify, map, and profile cellular ensembles and/or cell-types that produce and/or respond to opioids or that are engaged during different stages of opioid use (acute, chronic, withdrawal, abstinence, relapse). Emphasis is on single-cell resolution approaches that enable multimodal high-throughput functional mapping, anatomical characterization and molecular profiling of cell assemblies identified as targets of, or as primary sources of opioids in the brain.
Deadlines: 15 Sep 2021 (Optional LOI), 15 Oct 2021 (Application). This call is repeated once a year.
Amount: Applications may not request more than $700,000 direct costs for any one year. The maximum project period is 5 years.
Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit.
Keywords: Laboratory Animal Science, Molecular Cellular Entities, Opioids
* * * * *
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed)
RFA-DA-22-007 (U01 Clinical Trial Not Allowed)
NIDA invites mechanistic studies on the impact of social inequality on the brain and on the substance use trajectory. Applications investigating relevant mechanisms at the behavioral, cognitive, neurocircuitry, cellular, genetics, and epigenetics levels are encouraged. Applications testing a fully conceptualized and hypothesis-based solid premise founded with adequate preliminary data are appropriate for this FOA. Exploratory and high-risk research projects should consider applying to the companion R21 announcement RFA-DA-22-005.
Deadline: 14 Sep 2021 (Optional LOI), 14 Oct 2021 (Application). This call is repeated once a year.
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit.
Keywords: Brain, Cognitive or Behavioral Models, Epigenetics, Genetics, Inequality, Substance Abuse
* * * * *
NIDA Animal Genomics Program
PAR-21-244 (U01 Clinical Trial Not Allowed)
The purpose this program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1. Phenotypes associated with addictive behaviors and/or vulnerability to distinct stages along the substance use disorder (SUD) trajectory (e.g. initial/acute use, escalation of use, acquisition of tolerance, dependence, uncontrolled use, abstinence and relapse or recovery); 2. Behaviors associated with SUD (e.g. impulsivity, novelty seeking, delayed discounting, and other genetically-associated phenotypes); and 3. Comorbidities that demonstrate genetic correlations with phenotypes and behaviors linked with SUD (e.g. anxiety, stress, poor maternal care, social defeat, and other paradigms). Applications may examine any type of variant, including single nucleotide variants (SNVs), indels, large and small structural variants, and all types of mobile DNA. NIDA encourages applications that take genomics, multi-omics, and/or data-based approaches that integrate multi-level ‘omics data, delineate gene networks, and/or uncover the function of known or newly discovered genetic or epigenetic variants. NIDA expects these studies to uncover novel mechanisms that contribute to SUD and facilitate the discovery of targets for intervention and guide the development of individualized therapeutics to treat these different aspects of SUD.
Deadlines: 02 Mar 2022, 26 Jul 2022, 26 Jul 2022, 02 Mar 2023. This call is repeated once a year.
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Keywords: Addictions, Animal Models, DNA Sequencing, Epigenetics, Genetics, Genomics, Substance Abuse
* * * * *
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders
PAR-21-092 (UG3/UH3 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use. Eligible applicants must demonstrate the ability to develop molecules with the potential to treat SUDs and advance them in the drug development continuum. The ultimate goal of this FOA is to bring molecules closer to FDA approval.
Deadline: 25 Jul 2022, 25 Jul 2023. Optional Letter of Intent due 30 days prior. This call may repeat, variable.
Amount: Application budgets are limited to $1,000,000 direct costs per year and need to reflect the actual needs of the proposed project. The project period is limited to 2 years for the UG3 phase and 3 years for the UH3 phase.
Keywords: Heroin, Opioids, Substance Abuse, Substance Abuse Treatment, Tobacco
* * * * *
Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain
RFA-DA-22-009 (R01- Clinical Trial Optional)
NIH NIDA is acceptings applications to study mechanisms underlying the neuropathophysiology of HIV-associated neurological disorders (HAND) using induced microglia and cerebral organoids generated from human derived induced pluripotent stem cell (iPSC) lines. Specific emphasis is on the comorbidity of HIV and neural stimulants, including methamphetamine, amphetamine, cocaine, and nicotine, studied at the single cell and neural circuits levels.
Deadlines: October 17, 2021 (LOI) | November 17, 2021 (Application)
Amount: Up to $500,000 per year in direct costs. The maximum project period is 5 years.
Keywords: HIV/AIDS, Neurological Disorders, Stem Cells
* * * * *
Academic Research Enhancement Award for Undergraduate-Focused Institutions
PAR-21-154 (R15 - Clinical Trial Required)
PAR-21-155 (R15 Clinical Trial Not Allowed)
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions supports small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million per year of NIH support (in both direct and indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole.
Deadlines: 25 Oct 2021, 25 Feb 2022
Amount: Applicants may request up to $300,000 in direct costs for the entire project period of up to 3 years.
Keywords: Biomedical Research (Multidisciplinary), Biomedical Research Resources, Undergraduate Education, Biomedical Research (Multidisciplinary), Undergraduate Education
* * * * *
Imaging - Science Track Award for Research Transition (I/START)
PAR-18-918 (R03 Clinical Trial Optional)
This FOA encourages Small Research Grant applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs, to enable the conduct of small "proof of concept" studies. The R03 is intended to support research projects that can be carried out in a short period of time with limited resources.
Deadlines: October 16, 2021, February 16, 2022, or June 16, 2022
Amount: Budgets for direct costs of up to $150,000 per year and is for a period of one year only. The maximum project period is 1 year
Keywords: Neuroimaging, Radiology & Medical Imaging
* * * * *
NIDA Core "Center of Excellence" Grant Program
PAR-20-267 (P30 Clinical Trial Optional)
NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to substance use/misuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. An application should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to provide research opportunities and experiences to new investigators, and share findings, data and their resources, consistent with achieving the goals of the program.
Deadlines: 27 Sep 2021, 26 Sep 2022 (Confirmed: no future rounds expected)
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Keywords: Addictions, Clinical Trials, Drug Abuse Prevention, Drug Abuse Treatment, Substance Abuse, Substance Abuse Prevention, Substance Abuse Treatment
* * * * *
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research
PAR-20-249 (K12 Clinical Trial Optional)
This FOA encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research and career development experiences for clinician scientists (Scholars) leading to research independence in the area of substance use and substance use disorder research. For this FOA, clinician scientists may include (but are not limited to) physicians, clinical psychologists, epidemiologists, doctoral level social workers, pharmacists, and behavioral scientists. Scholars are expected to be supported for 3-5 years on consecutive 12-month appointments. Candidates selected for support as scholars must hold a doctorate and commit a minimum of 9 person months (equivalent to 75% of full-time professional effort) to conducting clinical research and career development activities associated with the proposed program.
Deadlines: 15 Nov 2021, 01 Mar 2022, 02 Aug 2022 (Confirmed: no future rounds expected)
Amount: Direct costs are limited to $500,000 per year. The project period duration may range from 3 to 5 years.
Keywords: Addictions, Drugs or Drug Abuse, Medical Education, Substance Abuse
* * * * *
Eligibility for NIDA FOAs (unless specificied): Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit.
Biomarkers for the Lewy Body Dementias
RFA-NS-22-001 (U01 Clinical Trial Not Allowed)
The purpose of this funding opportunity announcement (FOA) is to support hypothesis-driven clinical research applications that are focused on discovering novel diagnostic, prognostic, and/or therapeutic biomarkers for the Lewy Body Dementias (LBD). Biomarker research must be conducted in patients with LBD, must follow Parkinson's Disease Biomarker Program (PDBP) protocols for clinical assessment and biospecimen collection, and must be broadly shareable through the PDBP repositories.
Deadline: 22 Oct 2021. This call is repeated once a year.
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit
Keywords: Biological Markers & Sensor Mechanisms, Clinical Research or Studies, Parkinsons Disease
* * * * *
Longitudinal Single Cell Characterization of ADRD Postmortem Tissue
PAR-22-029 (R01 Clinical Trial Not Allowed)
The purpose of this funding opportunity is to support projects to identify cellular changes in ADRD post-mortem brain tissue across disease progression. Applicants are encouraged to propose single-nucleus transcriptomic and epigenomic studies that identify changes in neuronal, glial, or vascular cells over multiple ADRD stages, from early to mid-stage. All sequencing data and any available pre-mortem clinical data will be broadly shared with the research community.
Deadline: 05 Oct 2021. No information available for future renewals.
Amount: Application budgets are limited to $630,000 direct costs/year and need to reflect the actual needs of the proposed project. The maximum project period is 5 years
Keywords: Brain Disorders, Disease
* * * * *
Translational Neural Devices
RFA-NS-21-021 (U44 Clinical Trial Required)
This opportunity encourages investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption for a Significant Risk study or Institutional Review Board approval for a Non-Significant Risk study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.
Deadline: 20 Oct 2021, 18 Feb 2022, 20 Jun 2022, 18 Oct 2022. Optional Letter of Intent due 60 days prior. This call is repeated once a year.
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Applicants should rarely exceed $1,000,000 direct costs per year for the UG3 phase and $1,500,000 direct costs per year for the UH3 phase. The proposed project period for the UG3 phase must not exceed 4 years. The proposed project period for the UH3 phase must not exceed 4 years. The total duration of the UG3 and UH3 may not exceed 5 years.
Keywords: Applied Sciences, Clinical Research or Studies, Clinical Trials, Medical Devices, Medical Diagnosis, Nervous System, Neuromuscular Diseases, Novel Device Concepts
* * * * *
Translational Neural Devices (Small Business only)
RFA-NS-21-022 (UG3/UH3 - Clinical Trial Required)
NIH-NINDS encourages applications from Small Business Concerns (SBCs) to pursue translational activities and small clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities leading to submission of an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.
Deadlines: 20 Oct 2021, 18 Feb 2022, 20 Jun 2022, 18 Oct 2022. Optional Letter of Intent due 60 days prior. This call is repeated once a year.
Amount: Applicants should rarely exceed $1,000,000 in total costs per year during the SBIR Phase I and $1,500,000 in total costs per year during the SBIR Phase II. The total duration of both Phase I and Phase II must not exceed 5 years.
Eligibility: Small Business only
Keywords: Applied Chemistry, Clinical Research or Studies, Clinical Trials, Medical Devices, Medical Diagnosis, Nervous System, Neuromuscular Diseases, Novel Device Concepts
* * * * *
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders
PAR-21-056 (U01 Clinical Trial Optional)
The goal of this program is to enable the rigorous validation of analytical methods for biomarker measurements, which should include evaluation of the detection method, its performance characteristics, and the optimal conditions that will generate reproducibility and accuracy consistent with FDA guidelines. This PAR assumes that 1) a candidate biomarker has already been identified, 2) detection method technology has already been developed, and 3) the research and/or clinical need and potential context of use has been identified. Components of Participating Organizations: National Institute of Neurological Disorders and Stroke (NINDS)
Deadlines: 22 Feb 2022, 22 Jun 2021 *Anticipated*
Amount: Application budgets are not limited but should to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Keywords: Biological Markers & Sensor Mechanisms, Clinical Medicine, Clinical Trials, Neurological Disorders
* * * * *
NINDS Institutional Research Training Program
PAR-21-149 (T32 Clinical Trial Not Allowed)
NINDS institutional training programs are intended to be 1-2 years in duration and support training of one or more of the following groups: dissertation stage predoctoral students in their 3rd and/or 4th year of graduate school, postdoctoral fellows and fellowship-stage clinicians. (NINDS does not support first or second year graduate students under this PAR).
Deadlines: 25 May 2022 (confirmed), 25 May 2023 (anticipated), This call is repeated once a year.
Amount: Application budgets are not limited, but need to reflect the actual needs of the proposed project. Grantees are expected to be familiar with and comply with applicable cost policies and the NRSA Guidelines Funds may be used only for those expenses that are directly related to and necessary for the research training. Up to 5 years
Keywords: Clinical Research or Studies, Medical Education, Training and Development
* * * * *
Eligibility (unless specified): Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit, Small businesses.
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research
PAR-20-093 (P50 Clinical Trial Optional)
NIH-NIMH encourages applications for Conte Centers for Basic Neuroscience or Translational Mental Health Research. The purpose of these Centers is to support interdisciplinary teams of researchers engaged in novel, creative, and integrated experimental approaches to address high-risk, high-impact scientific questions that will significantly advance the state of the science in brain and behavioral research to ultimately provide the foundation for understanding mental disorders and/or transform the understanding and treatment of mental illnesses. Conte Centers exemplify a collaborative, cutting-edge, interdisciplinary research program conducted at multiple levels of analysis that may include genes, cells, synapses, circuits, behavior and/or disease states, in model systems or humans, and from the prenatal period throughout the lifespan. It is also expected that Conte Centers will develop data and other research resources and make them widely available to the scientific community.
Deadline: 24 May 2022. This is a one-off opportunity. We do not expect future rounds.
Amount: Direct costs are limited to $2 million in any one year. The total project period may not exceed 5 years. The total length of support for any Center is limited to a maximum of ten years.
Keywords: Behavioral Medicine, Behavioral Problems or Disorders, Brain, Child or Adolescent Mental Health, Child Psychology, Clinical Medicine, Clinical Research or Studies, Developmental Psychology, Mental Disorders, Mental Health, Neurology, Psychopathology
* * * * *
Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology
PAR-21-263 (R01 Clinical Trial Optional)
NIH-NIMH is soliciting applications for research projects that will use computational approaches to test the validity of dimensional constructs in the NIMH Research Domain Criteria (RDoC) matrix (or similar constructs based on comparable criteria). Some elements of the RDoC matrix have been updated since its first release, but a thorough data-driven validation that broadly explores, compares, and validates the constructs within the matrix has not been performed. This Research Project should address following questions: Do the different domains of behavior segregate from each other? How much do they rely on distinct versus overlapping neural circuits? What are the relationships between domains, constructs, and subordinate sub-constructs, both in terms of their correlational structure and their underlying neural circuitry? By answering these questions, proposed research projects will test integrative models of functioning and identify dysregulation in psychopathology-related mechanisms that may cut across traditional diagnostic categories and may change over time.
Deadlines: 01 Oct 2021 (LOI, optional), 01 Nov 2021 (Application). This call is repeated once a year.
Amount: Application budgets may not exceed $500,000 Direct Costs annually, including any consortium F&A, and are expected to reflect actual needs of the proposed project. The maximum project period is 5 years.
Keywords: Applied Sciences, Clinical Research or Studies, Computational Neuroscience, Medical Diagnosis, Mental Disorders, Mental Health, Neurology, Neurons, Psychopathology
* * * * *
Computationally-Defined Behaviors in Psychiatry
PAR-21-264 (R21 Clinical Trial Optional)
Applications are now being accepted for research projects that will apply computational approaches to develop parametrically detailed behavioral assays across mental-health relevant domains of function. These projects should focus on behavior in humans and test computational models in healthy, trans-diagnostic, unselected, or community samples. NIMH is particularly interested in the study of behavioral measures, models, and parameters that have the potential for back-translation from humans to animals, especially for pre-clinical therapeutics development, and in models that have the potential to be extended to clinical populations.
Deadlines: 01 Oct 2021 (LOI, optional), 01 Nov 2021 (Application). This call is repeated once a year.
Amount: Direct costs are limited to $275,000 over a two-year project period, with no more than $200,000 in direct costs allowed in any single year. The maximum project period is 2 years.
Keywords: Animal Models, Behavioral Medicine, Mental Health, Psychiatry, Therapy Evaluation
* * * * *
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders
PAR-21-132 (R01- Clinical Trial Required)
NIMH invites clinical trial applications through a series of Funding Opportunity Announcements (FOAs) that cover the intervention development pipeline, from first-inhuman, early testing of new interventions, confirmatory efficacy trials, through to effectiveness trials. The purpose of this FOA is to support confirmatory efficacy testing of non-pharmacological therapeutic and preventive interventions for mental disorders in adults and children through an experimental therapeutics approach. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support "go/no-go" decisions about further development, effectiveness testing, or dissemination of the intervention. Interventions to be studied include, but are not limited to behavioral, cognitive, interpersonal, and device-based (both invasive/surgically implanted as well as noninvasive/transcranial) approaches, or a combination thereof. Interventions appropriate for efficacy testing must be based on a compelling scientific rationale, previous demonstration that the intervention engages and alters the hypothesized mechanism of action, a preliminary efficacy signal, and must address an unmet therapeutic need. Support will be provided for a trial of the intervention's efficacy that includes measurement of the hypothesized mechanism of action and the relationship between change in the mechanism and change in functional or clinical effects. Ultimately, this FOA is intended to support a sufficiently-powered efficacy trial to determine the intervention's potential for significant clinical benefit. Applicants pursuing other stages of the clinical trial pipeline should consider one of the companion FOAs.
Deadline: 15 Oct 2021, 15 Feb 2022, 15 Jun 2022, 14 Oct 2022. Optional Letter of Intent due 30 days prior. This call is repeated once a year.
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Keywords: Behavioral Medicine, Cognitive Psychology, Medical Intervention Methods, Mental Disorders
* * * * *
Discovery of Cell-based Chemical Probes for Novel Brain Targets
PAR-21-028 (R21 Clinical Trial Not Allowed)
The opportunity supports investigators who have interest and capability to join efforts for the discovery of cell-based chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds ("validated hits") for chemical optimization and bioassays for testing new analog compounds. Through this program, NIH wishes to stimulate research in: 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of NIMH, NIDA, NEI and/or NIA; and 2) discovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes.
The main emphasis of projects submitted under this FOA should be the discovery of cell-based chemical probes. Applicants interested in developing in vivo chemical probes may wish to apply using the companion R01 mechanism, (PAR-21-029).
Application Deadlines: 16 Oct 2021, 16 Feb 2022. This is a one-off opportunity. We do not expect future rounds.
Amount: Direct costs are limited to $275,000 over a two-year period, with no more than $200,000 in direct costs allowed in any single year. The maximum project period is 2 years.
Keywords: Biochemical Markers, Biochemistry & Molecular Biology, Biological Markers & Sensor Mechanisms, Biological Sciences, Brain, Brain Disorders, Chemical Sciences, Immunological & Bioassay Methods, Molecular Biochemistry, Molecular Cellular Entities
* * * * *
Discovery of in vivo Chemical Probes for the Nervous System
PAR-21-029 (R01 Clinical Trial Not Allowed)
This opportunity supports investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds ("validated hits") for chemical optimization and bioassays for testing new analog compounds. NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of NIMH, NIDA, NEI, and/or NIA and 2) discovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes. The main emphasis of projects submitted under this FOA should be the discovery of in vivo chemical probes. Applicants interested in developing cell-based chemical probes may wish to apply using the companion R21 mechanism, (PAR-21-028).
Deadlines: 05 Oct 2021, 05 Feb 2022. This is a one-off opportunity. We do not expect future rounds.
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The total project period may not exceed 4 years.
Keywords: Biochemical Markers, Biochemistry & Molecular Biology, Biological Markers & Sensor Mechanisms, Biological Sciences, Brain, Brain Disorders, Chemical Sciences, Immunological & Bioassay Methods, Molecular Biochemistry, Molecular Cellular Entities, Pharmacokinetics
* * * * *
Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes
PAR-21-283 (R34 Clinical Trial Required)
This program supports pilot work for subsequent studies testing the effectiveness of strategies to deliver evidence-based mental health services, treatment interventions, and/or preventive interventions (EBPs) in low-resourced mental health specialty and non-specialty settings within the United States. The FOA targets settings where EBPs are not currently delivered or delivered with fidelity, such that there are disparities in mental health and related functional outcomes (e.g., employment, educational attainment, stable housing, integration in the community, treatment of comorbid substance use disorders) for the population(s) served. Implementation strategies should identify and use innovative approaches to remediate barriers to provision, receipt, and/or benefit from EBPs and generate new information about factors integral to achieving equity in mental health outcomes for underserved populations. Research generating new information about factors causing/reducing disparities is strongly encouraged, including due consideration for the needs of individuals across the life span. Applications proposing definitive tests of an implementation strategy should respond to the companion R01 announcement PAR-21-284.
Deadlines: 16 Oct 2021, 16 Feb 2022. Optional Letter of Intent due 30 days prior. This call is repeated once a year.
Amount: Direct costs are limited to $225,000 per year and $450,000 over the 3-year project period. Project period cannot exceed three years.
Keywords: Health of Underserved Populations, Health Services Delivery, Mental Health Services
* * * * *
Innovative Mental Health Services Research
PAR-21-316 (R01 Clinical Trials Not Allowed)
NIH-NIMH encourages innovative research that will inform and support the delivery of high-quality, continuously improving mental health services to benefit the greatest number of individuals with, or at risk for developing, a mental illness. This announcement invites applications for non-clinical trial R01-level projects that address NIMH strategic priorities that strengthen the public health impact of NIMH-supported research as described in Goal 4 of the NIMH Strategic Plan. Proposed research should seek to:
Deadlines: 05 Oct 2021, 05 Feb 2022. This call is repeated once a year.
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed budget. However, applicants requesting $500,000 or more in direct costs in any year (excluding consortium F&A) must contact a Scientific/Research Contact...
Keywords: Health Disparities, Health Services Delivery, Mental Health Services, Public Health
* * * * *
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders
PA-18-908 (R01 Clinical Trial Not Allowed)
The opportunity supports the development of advanced computational, bioinformatic and statistical tools to determine the functional relevance of genetic variants associated with mental disorders of complex etiologies identified through genome-wide association or sequencing studies. The overarching goal of this initiative is to support the development of innovative computational methods that facilitate the elucidation of the functionality of genetic variants associated with mental illness, taking into account the added complexities and nuances of brain diseases, and to ultimately inform novel treatment development based on human biology.
Deadline: 05 Oct 2021, 05 Oct 2022. Optional Letter of Intent due 30 days prior. This call is repeated once a year.
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Keywords: Bioinformatics, Brain Disorders, Computational Biology, Deoxyribonucleic Acid, DNAGenesGenetic Disorders, Genetics, Mental Disorders
* * * * *
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide
RFA-MH-21-110 (R01 Clinical Trial Optional)
RFA-MH-21-111 (R34 Clinical Trial Optional)
RFA-MH-21-112 (R43/R44 Clinical Trial Optional)
NIMH seeks applications for research projects to evaluate the effectiveness of service-ready tools and technologies that can be used to advance training, quality monitoring, and quality improvement efforts and ultimately improve the availability of evidence-based suicide prevention services. Specifically, this initiative encourages research on the effectiveness-implementation continuum aimed at (1) developing and testing the effectiveness of optimized, service-ready suicide prevention tools for identification, prevention, and treatment of individuals at risk for suicide; and (2) testing strategies to improve adoption, implementation fidelity, and sustained use of these tools, guided by an implementation science framework. Given the focus on practice-ready accessible resources and products that could be readily integrated into practice, NIMH encourages the use of technology and other design features that make the tools scalable and robust against implementation drift, and a deployment-focused approach that takes into account the perspectives of key stakeholders (e.g., service users, providers, administrators) and system-level factors, such as workforce capacity that influence potential integration of tools into clinical workflows. This FOA is intended to support effectiveness research of service-ready tools and technologies for suicide prevention that are statistically powered to provide a definitive answer regarding the study tool's effectiveness. Support for pilot effectiveness research to evaluate the initial feasibility, tolerability, acceptability, safety, and preliminary indications of effectiveness of service-ready tools and technologies for suicide prevention is provided via the R34 in RFA-21-111.Support for SBIR studies focused on service-ready tools and technologies or suicide prevention is provided via the R43/R44 in RFA-21-112.
Deadline: 15 Oct 2021, 18 Feb 2022, 15 Jun 2022. Optional Letter of Intent due 60 days prior. No information available for future renewals
Amount: (R01/R34) Application budgets are not limited but need to reflect the actual needs of the proposed project. Scope of the proposed project should determine the project period. The maximum period is 5 years, however, most awards will be for 3-4 years. (R43/R44) - See FOA
Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Small Business only
Keywords: Data Management or Analysis (Medical), Outcomes Research (Medical), Suicides & Suicide Attempts
* * * * *
Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia
PAR-20-235 (R01 Basic Experimental Studies with Humans Required)
NIH-NIMH encourages research to develop task-based behavioral measures that are shown to engage brain systems relevant to anhedonia using neuroimaging or other brain measures with similar spatial resolution. The goal is to identify behavioral tasks that can be used as quantitative tools in future studies of the functional constructs associated with anhedonia and in treatment development. This FOA is for basic science experimental studies involving human participants that fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of brain function in healthy individuals or those with disorders.
Deadlines: October 05, 2021, February 05, 2022, June 05, 2022
Amount Available: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. The maximum project period is 5 years.
Keywords: Animal Models, Brain Disorders, Cognitive Development or Processes, Computational Neuroscience, Computer Modeling, Neural Stimulation, Neurological Disorders, Neurophysiology, Neuropsychiatry
* * * * *
Novel Mechanism Research on Neuropsychiatric Symptoms in Alzheimer's Dementia
PAR-20-157 (R01 Clinical Trial Optional)
PAR-20-159 (R21 Clinical Trial Optional)
NIN-NIMH invites applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD.
R01 Application Due Date (s): October 05, 2021, February 05, 2022, June 05, 2022
R21 Application Due Date (s): October 16, 2021, February 16, 2022, June 16, 2022
Amount Available: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. The maximum project period is 5 years
Keywords: Alzheimers Disease, Dementia, Neuropsychiatry
* * * * *
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity
PAR-21-175 (R01 Clinical Trial Optional)
PAR-21-176 (R21 Clinical Trial Optional)
THis FOA supports projects that test whether modifying electrophysiological patterns during behavior can improve cognitive, affective, or social processing. Applications must use experimental designs that incorporate active manipulations to address at least one, and ideally more, of the following topics: (1) in animals or humans, determine which parameters of neural coordination, when manipulated in isolation, improve particular aspects of cognitive, affective, or social processing; (2) in animals or humans, determine how particular abnormalities at the genomic, molecular, or cellular levels affect the systems-level coordination of electrophysiological patterns during behavior; (3) determine whether in vivo, systems-level electrophysiological changes in behaving animals predict analogous electrophysiological and cognitive improvements in healthy persons or clinical populations; and (4) use biologically-realistic computational models that include systems-level aspects to understand the function and mechanisms by which oscillatory and other electrophysiological patterns unfold across the brain to impact cognitive, affective, or social processing.
R01 Application Due Dates: October 05, 2021, February 05, 2022, June 05, 2022
R21 Application Due Dates: October 16, 2021, February 16, 2022, June 16, 2022
Amount Available: R01: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. The maximum project period is 5 years. R21: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
Keywords: Animal Models, Brain Disorders, Cognitive Development or Processes, Computational Neuroscience, Computer Modeling, Neural Stimulation, Neurological Disorders, Neurophysiology, Neuropsychiatry
* * * * *
Eligibility (Unless specified): Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit. See FOA for small businesses eligibility.
Research to Improve Native American Health
PAR-20-214 (R21 Clinical Trials Optional)
The purpose of this funding opportunity announcement (FOA) is to support developmental/exploratory studies in preparation for health promotion, disease prevention, treatment, or treatment services research to improve health in Native American (NA) populations. Existing data suggest that significant acute and chronic disease inequities exist for NA populations. Concurrently, NA populations experience unique sociopolitical, historical, and environmental stressors and risks that may exacerbate health conditions and/or impact the effectiveness of existing solutions to address the conditions. They also possess unique strengths and resiliencies that can mitigate stressors or inform intervention strategies. Through this announcement, culturally informed exploratory/developmental research is sought that builds upon community knowledge, resources, and resilience to provide foundational knowledge for future science-based, culturally appropriate solutions to reduce morbidity and mortality through identification and remediation of precursors to diseases and disorders and through culturally informed treatment.
Deadlines: 07 Sep 2022, 17 May 2023, 07 Sep 2023. Optional LOI due 30 days prior. This is a one-off opportunity. We do not expect future rounds.
Amount: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in a single year. The scope of the proposed project should determine the project period. The total project period may not exceed 2 years.
Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Individuals: Early Career and Emerging in Field, Individuals: Mid-Career to Established in Field, Non-profit, Small Business only
Keywords: Alcoholism Prevention, Disease Prevention, Epidemiology, Health Care, Health Promotion, Mental Health, Native North Americans, Quality of Life, Smoking Behavior, Substance Abuse
Investigator-Initiated Research Award
W81XWH-21-CPMRP-IIRA
The intent of the FY21 CPMRP IIRA is to support studies that have the potential to make significant advances in research, patient care, and/or quality of life in the FY21 CPMRP IIRA Focus Areas. Amount Upper: $900,000 USD
Clinical Exploration Award
W81XWH-21-CPMRP-CEA
The intent of the FY21 CPMRP CEA is to support proof-of-principle pilot studies, clinical trials, and correlative studies to investigate hypothesis-based, innovative interventions and/or avenues of research that have the potential to resolve current clinical barriers and result in a profound impact on the management of chronic pain. Amount: $250,000 USD
Deadline: November 12, 2021
Eligibility: All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply.
Keywords: Chronic Pain, Quality of Life, Rehabilitation or Therapy
CRRP RDTRA Award
W81XWH-21-S-CRRP
The CRRP seeks to enhance medical capabilities and Force readiness at the point of greatest need in order to save the most lives in trauma care scenarios, which may be complicated by combat operations, limited resources, austere conditions, and/or mass casualty events. The intent of the FY21 CRRP RDTRA is to support research that will accelerate the movement of promising ideas into clinical applications, including healthcare products, technologies, and/or practice guidelines. Research under this award mechanism should represent a rapid advancement or innovative;leap ahead; and have the potential for broadly applicable, cross-cutting advances benefiting military health and medicine as well as the general public.
Important Dates (s): December 01, 2021
Amount Available: Upper: $1,800,000 USD - 2 years
Eligibility: All organizations, including international organizations, are eligible to apply.
Keywords: Combat Medical Care, Trauma and Emergency Surgery, Traumatology, Accidents & Injury, Wound Healing
HPW/RHX Award
FA8650-18-S-6001
This effort is an open 2 Step BAA soliciting innovative research concepts for the overall mission of the Human-Centered Intelligence, Surveillance, & Reconnaissance (ISR) Division (711 HPW/RHX).The overall RHX research objective is to develop human-centered S&T that enables the Air Force to more effectively execute the ISR mission. This research objective is dual natured: (1) improve the capability to identify, track and locate human targets in the ISR environment and (2) improve the performance of humans who process, exploit, analyze, produce, and disseminate the ISR data and information. Human-centered ISR research encompasses three major research areas: (1) human signatures, (2) human trust and interaction and (3) human analyst augmentation. The human signatures research develops technologies to sense and exploit human bio-signatures at both the molecular level and macro (anthropometric) level. The human trust and interaction research develops technologies to improve human-to-human interactions as well as human-to- machine interactions. The human analyst augmentation research develops technologies to enhance analyst performance and to test the efficacy of newly developed technologies within a simulated operational environment.
Amount Available: $1,600,000
Important Dates (s): February 10, 2023
Keywords: Human Performance (Military), Natural and Physical Sciences, Mathematics and Technology, Target Recognition Systems
Early Investigator Research Award
W81XWH-21-MSRP-EIRA
The Early Investigator Research Award supports MS-focused research opportunities for individuals in the early stages of their careers, under the guidance of one or more designated Mentors. Amount Upper: $200,000 USD
Clinical Trial Award
W81XWH-21-MSRP-CTA
The MSRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. Amount: $3,000,000
Exploration - Hypothesis Development Award
W81XWH-21-MSRP-EHDA
The Exploration - Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the MS research field. Amount: $150,000 USD
Investigator-Initiated Research Award
W81XWH-21-MSRP-IIRA
The IIRA supports highly rigorous, high-impact research projects that have the potential to make an important contribution to MS research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. Amount: $600,000 USD
Important Dates (s): October 1, 2021
Eligibility: All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply.
Keywords: Multiple Sclerosis, Clinical Trials, Multiple Sclerosis, Etiology Multiple Sclerosis, Neurodegenerative Diseases
Clinical Trial Award
W81XWH-21-S-TBIPH1
CTA supports the rapid implementation of clinical trials with the potential to have a significant impact on TBI and/or psychological health through clinical applications, including healthcare products, technologies, and/or practice guidelines. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, therapies, clinical guidance, emerging approaches and technologies, and/or new indications for products currently FDA-approved or -cleared. Clinical trials may also be designed to evaluate novel methods for improving dissemination and implementation or investigate the mechanisms of action of new interventions
Focused Program Award
W81XWH-21-S-TBIPH2
The intent of the FY21 TBIPHRP FPA is to optimize research and accelerate solutions to a critical question related to at least one sub-area within one of the three FY21 TBIPHRP FPA Focus Areas. The award mechanism supports development of a synergistic, multidisciplinary research program with the potential to have a significant impact on TBI and/or psychological health through clinical applications, including healthcare products, technologies, and/or practice guidelines.
Translational Research Award
W81XWH-21-TBIPHRP-TRA
The FY21 TBIPHRP TRA is intended to support translational research that will accelerate the movement of promising ideas in TBI and/or psychological health research into clinical applications, including healthcare products, technologies, and/or clinical practice guidelines.
Deadlines: Nov 1, 2021 (Pre-Application) ; December 16, 2021 (Application)
Eligibility: All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply.
Keywords: Traumatic Brain Injury, Medical Intervention Agents & Methods, Clinical Research or Studies, Clinical Trials
Early Investigator Research Award
W81XWH-21-NETP-EIRA
The NETP Program IIRA supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to neurotoxin exposure and treatment-related Parkinson's research. This award mechanism supports the full spectrum of research from basic science through clinical research. Amount: $1,200,000 USD
Investigator-Initiated Research Award.
W81XWH-21-NETP-IIRA
The NETP Program IIRA supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to neurotoxin exposure and treatment-related Parkinson's research. This award mechanism supports the full spectrum of research from basic science through clinical research. Amount $1,200,000 USD.
Synergistic Idea Award
W81XWH-21-NETP-SIA
The NETP Program Synergistic Idea Award supports new ideas that represent synergistic approaches to neurotoxin exposure and treatment-related PD research involving two to four Principal Investigators (PIs) at the Assistant Professor (or equivalent) level or above. (Amount Upper: $3,000,000 USD)
Deadline: September 29, 2021
Eligibility: All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply.
Keywords: Clinical Research or Studies, Neurotoxicology Parkinsons Disease
Investigator-Initiated Study Program (IIS)
Aesculap
Aesculap is committed to supporting researchers interested in conducting studies of their own design which promotes the advancement of medical and scientific knowledge related to Aesculap's products and therapeutic areas of focus:
Deadline: Continuous, You can apply for this opportunity at any time
Amount: Support may be provided by Aesculap and is dependent on the type of research and availability of support.
Eligibility: Researchers may initiate the application process.
Keywords: Biomedical Materials, Biotechnology, Medical Technology, Neurosurgery, Orthopedics, Spinal Cord Diseases, Spinal Cord Injury, Surgery & Intensive Care
Misha Mahowald Prize
iniLabs
iniLabs invites applications for the Misha Mahowald prize. This recognises achievements in the field of neuromorphic engineering. Neuromorphic engineering is defined as the construction of artificial computing systems which implement key computational principles found in natural nervous systems. Neuromorphic Engineering is a new emerging interdisciplinary field which takes inspiration from biology, physics, mathematics, computer science and engineering to design hardware/physical models of neural and sensory systems.
Deadline: 31 Oct 2021 (Application) - This call is repeated once a year.
Amount: The prize is worth USD 10,000.
Eligibility: Any individual or research group worldwide may apply.
Keywords: Artificial Intelligence or Cybernetics, Computational Neuroscience, Machine Learning
Global Awards for Advancing Chronic Pain Research (ADVANCE)
ADVANCE Adwards
Pfizer Inc. and Eli Lilly and Company are pleased to announce the call for proposals for the 3rd Global Awards for Advancing Chronic Pain Research (ADVANCE), an independently-reviewed, competitive grants program. Our mission is to fund innovative, novel research proposals that seek to advance the understanding and management of chronic pain.
Proposals will be reviewed by an external multidisciplinary, Independent Review Committee comprising renowned, global experts in chronic pain. Proposals will be reviewed based on area of interest, originality, scientific merit, and feasibility. Areas of research that are considered in-scope for an ADVANCE research grant, with the condition of interest being osteoarthritis (OA) and chronic pain associated with OA.
Deadline: 15 Sep 2021 (Application) - This call is repeated once a year.
Amount: A total of US $1,000,000 will be available to fund approximately 5 individual research proposals of between US $50,000 and US $200,000. The study must start within 6 months of contract execution and the duration of study treatment and follow-up should not exceed 2 years.
Eligibility: The Principal Investigator holds a doctoral degree (MD, PhD, PharmD, or equivalent). Proposals should have one Principal Investigator but can include multiple co-investigators. Investigators must be affiliated with an academic or medical institution.
Keywords: Chronic Pain, Osteoarthritis
Futures Forum on Learning - Tools Competition
Schmidt Futures
Last year, the Futures Forum on Learning launched the global Tools Competition to fund edtech tools, technologies, and platforms to combat the crisis of pandemic-related learning loss and build the field of learning engineering. We are excited to announce that this year’s Learning Engineering Tools Competition is now open.
Key themes for this year’s competition include accelerated learning, assessment, adult learning, and research-driven experimentation.
The Tools Competition aims to spur the development and deployment of technologies that address pressing education issues in elementary and secondary education and adult learning while advancing the field of learning engineering. Rather than designing silver bullet solutions, these tools will be designed for continuous improvement to maximize their effectiveness over time.
Learning engineering is an emerging discipline at the intersection of learning science and computer science that seeks to design learning systems with the instrumentation, data, and partnerships with the research community to drive tight feedback loops and continuous improvements in how that learning is delivered in online and blended settings. More information on this opportunity.
Amount: Entrants are encouraged to seek awards that are best suited for their specific capabilities and needs. Entrants will be subject to different requirements depending on the size of the award that they are seeking:
The funding is a prize, not a grant. Therefore, there are no specific requirements on what costs are allowed or not allowed (within reason, of course). There are no specific requirements around indirect costs, either.
There is no definitive time period for the award. It is recommended that awarded proposals demonstrate significant progress by Product Review Day in Summer 2022 to receive the second installment of funds. This progress will be measured against the timeline for execution outlined in the proposal. In addition to the prize funds, winners will have the opportunity to connect with prominent education researchers, edtech leaders, and representatives of large philanthropic organizations to scale their work.
Deadline: 01 Oct 2021 (Concept Paper), 17 Dec 2021 (Proposals) - This call is repeated once a year.
Eligibility: Technologists, digital learning platforms, researchers, students and teachers from around the globe are invited to apply. Anyone 18 years or older is eligible.
Keywords: Early Childhood Education, Educational Improvement, Educational Restructuring, Education or Instructional Programs, Elementary or Secondary Education, Human Learning and Memory, Mathematics Education, Middle School Education, Reading Education, School Health
ADDF Prevention Beyond the Pipeline
The ADDF seeks to support studies of cognitive symptoms due to health conditions, comparative effectiveness research, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. The Prevention Pipeline RFP supports: Studies of Cognitive Decline and Risk Reduction: Cognitive decline through aging and health conditions has been linked to an increased risk of dementia. The ADDF will consider funding programs to prevent and treat these conditions, including menopause-related cognitive symptoms, postoperative delirium and postoperative cognitive decline, mild and/or repetitive traumatic brain injury, and chemotherapy-induced decline. Methods may include epidemiology or clinical trials.
Application Due Date (s):
October 1, 2021 (LOI), December 3, 2021 (Full Proposal) - Anticipated
May 28, 2022 (LOI), July 30, 2022 (Full Proposal) - Anticipated
February 5, 2022 (LOI), April 16, 2021 (Full Proposal) - Anticipate
Amount Available: Up to $3,000,000 for clinical trials based on stage and scope of research.
Eligibility: Funding is open to researchers and clinicians worldwide at: Academic medical centers and universities or nonprofits. Industry partnerships are strongly encouraged. Biotechnology companies.
Keywords: Alzheimers Disease, Clinical Trials, Dementia, Epidemiology, Preventive Medicine
* * * * *
Neuroimaging and CSF Biomarker Development Program
The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use. Specifically, this RFP focuses on: developing novel PET ligands for clinical trials supporting novel CSF biomarkers validating established MRI approaches in larger cohorts; Novel biomarkers of neuroinflammation, synaptic integrity, autophagy and TDP-43 are high priority. Other target areas of interest include: Neuronal loss, Vascular injury and blood-brain barrier integrity. Mitochondria and metabolic function. Protein misfolding. Oxidative stress, White matter changes, Lewy body dementia, Other novel targets supported by compelling biological rationale and connection to disease.
Application Due Date (s):
October 1, 2021 (LOI), December 3, 2021 (Full Proposal) - Confirmed
May 28, 2022 (LOI), July 30, 2022 (Full Proposal)- Anticipated
February 5, 2022 (LOI), April 16, 2021 (Full Proposal) - Anticipated
Amount Available: Up to $600,000 based on stage and scope of research. Average Duration: One year with potential for follow-on funding. Multi-year proposals can be considered. Allowable Only direct costs are allowed.
Eligibility: Funding is open to researchers and clinicians worldwide at: Academic medical centers and universities or nonprofits. Industry partnerships are encouraged. Biotechnology companies. Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. Existing companies and new startups are both eligible.
Keywords: Alzheimers Disease, Biological Markers & Sensor Mechanisms, Dementia, Neuroimaging
Bi-Annual Grant
Our Bi-Annual membership grants deliver funding for programs and services that help further AFA’s mission of providing support, services and education to individuals, families and caregivers affected by Alzheimer’s disease and related dementias nationwide.
Deadline: 19 Feb 2022 (Spring Cycle - Application), 27 Aug 2022 (Fall Cycle - Application) - This call is repeated once a year.
Amount: $6,000USD
Eligibility: United States Non-profit
Keywords: Alzheimers Disease, Brain Disorders, Dementia Health Services Delivery, Huntingtons Disease, Medical Education, Neurological Disorders, Parkinsons Disease, Quality of Life Program
Young Investigator Innovation Grants
All AFSP research grants are designed to support research on suicide from a variety of disciplines including psychiatry, medicine,psychology, genetics, epidemiology, neurobiology, sociology, nursing, health services administration, social work, and many others. Grants are not intended to support the development or implementation of prevention programs, educational programs, treatments, or other interventions that do not have a significant research component. An additional purpose of the Young Investigator Grant is to assist new researchers to obtain the advice, guidance and supervision of an established mentor in a selected area of suicide research.
Deadline: 15 Nov 2021 (Application) - This call is repeated once a year.
Amount: Up to $90,000 over 2 years
Eligibility: AFSP research grants and fellowships are awarded to individuals affiliated with not-for-profit institutions or organizations in the U.S. and abroad. Grant applications are not accepted from for-profit organizations, or from federal or state government agencies. Applications from the Veterans Administration are eligible. Applications from both private and public colleges and universities are eligible so long as the institution is not-for-profit.
Keywords: Chronic Pain, Drugs or Drug Abuse LGBTQ Studies, Mental Health, Psychiatry, Psychology, Substance Abuse, Suicides & Suicide Attempts
Ruane Prize for Outstanding Achievement in Child and Adolescent Psychiatric Research
This prize was initiated in 2000 by philanthropists Joy and William Ruane to recognize important advances in understanding and treatment of early-onset brain and behavior disorders.
Deadline: 12 May 2022 (Nomination) - Anticipated, Funder deadline - required
Amount: This prize carries an award of $50,000 and the winner(s) is honored at the annual International Awards Dinner in New York City in October.
Eligibility: Individuals: Early Career and Emerging in Field. Individuals: Mid-Career to Established in Field
Keywords: Behavioral Problems or Disorders, Brain Disorders, Child or Adolescent Mental Health, Child Psychiatry
* * * * *
NARSAD Independent Investigator Grants
The BBRF Independent Investigator Grant provides support for investigators during the critical period between the initiation of research and the receipt of sustained funding. A grant is provided to scientists at the associate professor level or equivalent who are clearly independent and have won national competitive support as a principal investigator. Please note that an assistant professor who is a principal investigator on a NIH R01 grant is now eligible for the BBRF Independent Investigator Grant. Basic and/or clinical investigators are supported, but research must be relevant to schizophrenia, major affective disorders, or other serious mental illnesses. The program is intended to facilitate innovative research opportunities.
Deadline: We are in the process of determining the acceptance period for the BBRF Independent Investigator Grant applications. Please join our email list and visit our website for updates or additional information in the upcoming months.
Amount: Up to $100,000 for two year or Up to $50,000 for one year
Eligibility: Individuals: Early Career and Emerging in Field. Individuals: Mid-Career to Established in Field
Keywords: Behavioral Problems or Disorders, Brain Disorders, Mental Disorders
* * * * *
Scientific Innovations Award (SIA)
Brain Research Foundation's Scientific Innovations Award Program provides funding for innovative science in both basic and clinical neuroscience. This funding mechanism is designed to support creative, exploratory, cutting edge research in well-established research laboratories, under the direction of established investigators. The objective of the SIA is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. It is expected that investigations supported by these grants will yield high impact findings and result in major grant applications and significant publications in high impact journals. Limited submission: BRF will only accept one LOI per institution.
Important Dates: 24 Jun 2022 - (LOI, Anticipated) | 28 Sep 2022 - (Application, Anticipated)
Amount Available: Each total award is limited to $150,000 (direct costs) for a two year grant period.
Eligibility: The nominated candidate must be a full-time associate professor or full professor at an invited US academic institution, working in the area of studies of brain function in health and disease.
Keywords: Behavioral Problems or Disorders, Brain, Clinical Research or Studies, Mental Health, Neuroscience, Sensory Integration Disorders, Sensory System
* * * * *
Young Investigator Grants
The Foundation's BBRF Young Investigator Grant (YI) program offers grants to enable promising investigators to either extend their research fellowship training or to begin careers as independent research faculty. The program is intended to facilitate innovative research opportunities and supports basic, as well as translational and/or clinical investigators. All research must be relevant to our understanding, treatment and prevention of serious psychiatric disorders such as: schizophrenia; bipolar; mood and anxiety disorders (for a complete list, see the front page of the application); or early onset brain and behavior disorders.
Application Dates: 25 Mar 2022 - Anticipated, this call is repeated once a year
Amount Available: BBRF Young Investigator Grant (YI) program offers up to $35,000 a year for up to two years.
Eligibility: Applicants must have a doctoral level degree (e.g., M.D. with [minimum PGY-IV] training, Ph.D., Psy.D., Pharm.D., etc.) and already be employed in research training or a faculty research position. The YI Grant is intended to support advanced post-doctoral fellows, instructors and assistant professors (or equivalent). Researchers need not be U.S. citizens.
Keywords: Addictions, Affective Disorders, Anxiety Disorders, Attention Deficit Disorder, Autism, Behavioral Problems or Disorders, Compulsive Behavior, Mental Depression, Mental Disorders, Neurobiology, Neurological Disorders Posttraumatic Stress Disorder, Schizophrenia
Physician-Scientist Institutional Award
Burroughs Wellcome Fund (BWF) is offering a second round of the Physician-Scientist Institutional Awards (PSIA) program which was instituted in 2017 to increase the number of single degree M.D.'s who enter research. The PSIA advisory committee will review novel and innovative proposals that demonstrate how institutions will utilize a grant from BWF that outlines opportunities and support for the M.D. (only) to pursue training that will enable her/him to launch and continue a successful career as an independent investigator.
Application Date(s): 15 Feb 2022 (Anticipated, This call is repeated once a year)
Amount Available: Up to five awards ($2,500,000 each) will be made in this program cycle.
Eligibility: Medical schools in the United States and Canada
Keywords: Biochemistry & Molecular Biology, Biological Sciences, Biomedical Research (Multidisciplinary), Biomedical Research Resources, Biomedical Research Training, Biophysics, Energy Biological or Biomedical Sciences
Substance Abuse Research Grants
In the summer of 2019, the Centers for Disease Control reported the first decline in drug overdose deaths since 1990. However, the most recent National Survey on Drug Use and Health report found that 1 in 12 American adults (18.7 million) have a substance use disorder. The impacts of substance abuse continue to undermine the strength of our communities and more work needs to be done to combat this issue. In recognition of International Overdose Awareness Day, the Charles Koch Foundation seeks to support research projects (e.g. papers, conferences, workshops, etc.) that explore innovative, community-based solutions that are targeted at destroying the root causes of substance abuse. To that end, we are actively soliciting proposals for projects to consider innovative solutions that seek to alleviate substance use disorders. We are especially interested in research that: Addresses innovative ways to help individuals overcome substance use disorders, prevent drug overdoses, and increase the willingness of individuals to seek treatment for substance abuse.- Explores the root causes of addiction and substance use disorders as well as innovative means to prevent substance abuse by remedying these root causes.- Addresses the unintended consequences of current approaches to reduce drug overdoses and substance abuse.- Examines solutions that offer a proactive approach to fighting addiction rather than a reactive approach focusing on treatment and recovery.- Explores opportunities to reduce the stigma associated with substance use disorders and celebrate success in overcoming addiction and substance abuse.
Application Date(s): Proposals will be accepted and evaluated on a rolling basis.
Amount Available: Grant amounts are not specified.
Eligibility: Academic Institution, Non-profit
Keywords: Addictions, Opioids, Substance Abuse, Substance Abuse Prevention, Substance Abuse Treatment
Medline Foundation
Medline Foundation is investing resources to help non-profit organizations address prevalent health challenges, stimulate health equity and improve population health in under resourced areas. We will award results-focused grants that offer community- centered solutions and immediate impact. Through collaboration with community experts, we can provide essential resources, re-direct adverse outcomes and improve the well-being of people. This is, and always will be, our ongoing commitment to communities.
Important Dates (s): Anticipated - August 27, 2022
Amount: Individual grants are capped at $25,000. Grant Recipients will be announced in October 2021.
Eligibility: Non-profit organizations are eligible to apply. Must be based in the U.S. and its territories. To be considered, applications must be completed in full and submitted online. Submitting an application does not guarantee funding. Healthcare providers are not eligible to apply for this grant opportunity.
Comparative Effectiveness Research Award
The Comparative Effectiveness Research Award in Neuroradiology was created to support. investigators in the generation and synthesis of evidence that compares the benefits and harms of diagnostic imaging methods or interventions to prevent, diagnose, treat and monitor a clinical condition or to improve the delivery of care. Comparative Effectiveness Research (CER) is valuable to clinicians, patients, purchasers, and policy makers in making informed decisions that will improve health care at both the individual and population levels. For example, CER projects may include the direct comparison of diagnostic imaging modalities or interventions for a specific disease in a study population. Neuroradiologists have an important role in the development of new imaging technologies and image-guided procedures, as well as in the assessment of these techniques in the clinical care of patients.
*Anticipated* Application Due Date (s): November 2, 2021
Eligibility: A candidate must be a member of ASNR in good standing with an MD or DO degree, and must be board-certified or board-eligible in Radiology by either the American Board of Radiology or the Royal College of Physicians and Surgeons of Canada (RSPSC). A candidate must have completed a residency in Diagnostic Radiology and be enrolled in or have completed an ACGME-approved fellowship in neuroradiology or a fellowship in Pediatric Neuroradiology by the award period. Junior faculty are encouraged to apply. The candidate must be under the direct supervision of an ASNR Senior Member, who is willing to act as a mentor and project supervisor.
* * * * *
Scholar Award in Neuroradiology Research
The Scholar Award in Neuroradiology Research was created to provide funding opportunities for investigators not yet professionally established in neuroimaging research, and to obtain experience and competency in newly developing fields within neuroradiology. Scientific research is the foundation upon which the clinical practice of neuroradiology is built. Neuroradiologists must be leaders in the development of new imaging technologies and image- guided procedures, as well as in assessment of the roles of these technologies and procedures in the care of patients. The directive of this award is to train individuals in neuroscience research in important areas. Although any research area in neuroradiology will be considered, the awards emphasize the application of techniques in basic science research to diagnostic and/or interventional neuroradiology.
*Anticipated* Application Due Date (s): November 2, 2021 (LOI) | January 19, 2022 (Full Proposal)
Amount Available: The total award amount is up to $60,000 for one year (direct costs only).
Keywords: Neuroimaging, Radiology & Medical Imaging
* * * * *
Collaborative Neuroimaging Research Grant
The Collaborative Neuroimaging Research Grant was created to foster innovative collaboration between neuroradiology physicians and scientists. This grant is intended to provide joint collaborative opportunities for MD, PhD, and MD-PhD investigators to work together in advancing the science of neuroradiology. Scientific research is the foundation upon which the clinical practice of neuroradiology is built. Partnerships between neuroradiology clinicians and scientists have traditionally led the development, translation, and implementation of new imaging technologies and image-guided procedures. The directive of this award is to train physicians and scientists in collaborative neuroimaging research. Although any research area in neuroradiology will be considered, the award emphasizes the development of innovative diagnostic and interventional neuroradiology techniques, or basic science research with a translational component.
*Anticipated* Application Due Date(s): November 2, 2021 (LOI) ; January 19, 2022 (Full Proposal)
Amount Available: $120,000
Keywords: Neuroimaging / Neurology / Radiology & Medical Imaging
* * * * *
Neuroradiology Research Grant in Artificial Intelligence
ASNR Research Grant in Artificial Intelligence is created to provide a funding opportunity for investigators who are not fully established as neuroimaging researchers and who are interested in the emerging field of artificial intelligence in neuroradiology. Scientific research remains the foundation upon which the clinical practice of neuroradiology is built, and artificial intelligence is likely to have a transformative influence on the field of neuroimaging. Researchers in artificial intelligence will become the leaders who develop and translate this emerging technology into the routine clinical care of patients and go on to obtain extramural funding to support their research program. The overarching goal of this grant initiative is to foster the growth of individuals in this important and rapidly evolving field of artificial intelligence. Although any research in the field of artificial intelligence will be considered, the award emphasizes the application or translation of artificial intelligence methodology into neuroimaging practice including work flow, health services and access, diagnosis, treatment management, outcome assessment, prognostication, and biomarker development.
*Anticipated* Application Due Date (s): November 2, 2021 (LOI) | 19 January 19, 2022 (Full Proposal)
Amount Available: The total award amount is up to $60,000 for one year (direct costs only).
Eligibility: A candidate must be a member of ASNR in good standing with an MD or DO degree, and must be board-certified or board-eligible in Radiology by either the American Board of Radiology or the Royal College of Physicians and Surgeons of Canada (RSPSC).
Keywords: Artificial Intelligence or Cybernetics, Neuroimaging, Neurology, Radiology & Medical Imaging
Mayday Fund of New York Grants
The MAYDAY Fund is dedicated to alleviating the incidence, degree, and consequence of human physical pain.
The MAYDAY Fund has thematic grant-making targets, which evolve and change over time. MAYDAY has funded single-year projects as well as multi-year grants. Projects span the spectrum from bench science to education to professional practice. They address the role of patients, as well as that of professionals, rights, as well as responsibilities, and often crosscut our grant-making targets.
The MAYDAY Fund's current grant-making targets are projects to address the following needs:
Deadline: Continuous, You can apply for this opportunity at any time.
Amount: When appropriate, MAYDAY contributes an indirect costs allowance of 10 percent.
Eligibility: Grants are made only to public charities and educational institutions officially recognized as such by the IRS.
Keywords: Alternative Medicine, Biomedical Research (Multidisciplinary), Chronic Pain, Hospice & Palliative Care, Pain
McKnight Scholar Awards
The Scholar Awards support young scientists who: hold an M.D. and/or Ph.D. degree; have completed formal postdoctoral training; and demonstrate a commitment to neuroscience. The Endowment Fund especially seeks applicants working on problems that, if solved at the basic level, would have immediate and significant impact on clinically relevant issues. McKnight Scholars have generated some key findings about neuroscience, including: The discovery of receptors that encode the senses of smell, taste, and thermal pain. The first crystal structure of one of the ion channels that control the excitability of neurons. The discovery of neurotrophic factors that promote neuronal survival. The identification of molecules that promote axon growth and regeneration in the nervous system. The discovery of proteins in the nerve terminal that mediate the release of neurotransmitters. The identification of genes that control short- and long-term memory.
Application Due Date (s): January 4, 2022 - Anticipated / sponsor
Amount Available: Up to $225,000, 3-years
Eligibility: Candidates for the McKnight Scholar Awards must have: An M.D., Ph.D., or other suitable doctorate / A record of meritorious research / Evidence of a commitment to a career in neuroscience / Full-time appointment at the rank of Assistant Professor / and must have served at that rank for less than four years at the application deadline. Scientists holding other titles such as Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, Visiting Professor or Instructor are not eligible, and time spent in service in those ranks does not count against the four years of service for determining eligibility. Documentation that the sponsoring institution has government approval for the applicant to work in the U.S.
Keywords: Clinical Research or Studies, Human Learning and Memory, Learning Disorders, Neurological Disorders, Neuroscience
Collaborative Research in Computational Neuroscience (CRCNS)
Computational neuroscience provides a theoretical foundation and a rich set of technical approaches for understanding complex neurobiological systems, building on the theory, methods, and findings of computer science, neuroscience, and numerous other disciplines. This opportunity will advance the understanding of nervous system structure and function, mechanisms underlying nervous system disorders, and computational strategies used by the nervous system.
Two classes of proposals will be considered in response to this solicitation: (1) Research Proposals describing collaborative research projects, and (2) Data Sharing Proposals to enable sharing of data and other resources.
Deadline: 22 Nov 2022 (Application) - This is a one-off opportunity. We do not expect future rounds.
Amount Available: Anticipated Funding Amount: $5,000,000 to $20,000,000 per year, subject to availability of funds. Estimated Number of Awards: 20 to 25 per year
Eligibility: The categories of proposers eligible to submit proposals to the National Science Foundation are identified in the NSF Proposal & Award Policies & Procedures Guide (PAPPG), Chapter I.E. Unaffiliated individuals are not eligible to submit proposals in response to this solicitation.
Keywords: Computational Neuroscience, Nervous System
* * * * *
The Science of Learning and Augmented Intelligence Program
The Science of Learning and Augmented Intelligence Program (SL) supports potentially transformative research that develops basic theoretical insights and fundamental knowledge about principles, processes and mechanisms of learning, and about augmented intelligence - how human cognitive function can be augmented through interactions with others, contextual variations, and technological advances.
The program supports research addressing learning in individuals and in groups, across a wide range of domains at one or more levels of analysis including: molecular/cellular mechanisms; brain systems; cognitive, affective, and behavioral processes; and social/cultural influences.
The program also supports research on augmented intelligence that clearly articulates principled ways in which human approaches to learning and related processes, such as in design, complex decision-making and problem-solving, can be improved through interactions with others, and/or the use of artificial intelligence in technology. These could include ways of using knowledge about human functioning to improve the design of collaborative technologies that have capabilities to learn to adapt to humans.
Deadline: 19 Jan 2022 (Application), 14 Jul 2022* (Application) *Anticipated. This call is repeated once a year.
Eligibility: NSF welcomes proposals on behalf of all qualified scientists, engineers and educators.
Keywords: Artificial Intelligence or Cybernetics, Behavioral or Social Studies, Cognitive ScienceHuman Learning and Memory
* * * * *
Mind, Machine and Motor Nexus (M3X)
The Mind, Machine and Motor Nexus (M3X) program supports fundamental research at the intersection of mind, machine and motor. A distinguishing characteristic of the program is an integrated treatment of human intent, perception, and behavior in interaction with embodied and intelligent engineered systems and as mediated by motor manipulation. M3X projects should advance the holistic analysis of cognition and of embodiment as present in both human and machine elements. This work will encompass not only how mind interacts with motor function in the manipulation of machines, but also how, in turn, machine response and function may shape and influence both mind and motor function.
Deadline: Continuous, you can apply for this opportunity at any time.
Eligibility: Except where a program solicitation establishes more restrictive eligibility criteria, individuals and organizations in the following categories may submit proposals:
One Mind Rising Star Research Awards
The goal of the One Mind Rising Star Research Awards is to build capacity and accelerate research on neuropsychiatric disorders by recognizing and funding promising, early career investigators through a competitive grants process. One Mind, in collaboration with Inscopix, is also offering up to two supplemental technology grants, each in support of one Rising Star Research Award. The scope of the three 2021 Rising Star Awards varies as described below. Applicants will be considered for all that fit their proposal. The One Mind / Janssen Rising Star Award in Memory of Jeffrey S. Nye, MD, PhD, is open to proposals for translational research on any neuropsychiatric disorder. The One Mind Robina Riccitiello Rising Star Depression Research Award is open to proposals for translational and clinical research on depression and related disorders. The One Mind Donna Friedman Rising Star Eating Disorders Research Award is limited to translational and clinical research on eating disorders, such as anorexia nervosa, bulimia or compulsive eating disorders. Examples of relevant research proposals include, but are not limited to, studies that aim to: Discover causal mechanisms, biomarkers and therapeutic targets for neuropsychiatric disorders; Evaluate the effectiveness of therapies, including pharmaceuticals, electroceuticals, digital therapies or cognitive and behavioral health interventions to prevent the onset or promote recovery of neuropsychiatric disorders; Investigate common mechanisms of brain dysfunction and/or recovery between two or more neuropsychiatric or neurological disorders to accelerate the development of diagnostic tools, effective treatments and precision medicine; Improve our understanding of how age, race/ethnicity, and/or comorbidities impact the diagnosis, prognosis and treatment effectiveness of neuropsychiatric disorders; Integrate preclinical and clinical studies to accelerate and enhance translational research on neuropsychiatric disorders and recovery.
*Anticipated* Application Due Date (s): Jun, 1, 2022, project period, 3-years
Amount Available: Up to $300,000
Eligibility: To qualify as an early career investigator, candidates should be within 10 years of their initial independent appointment as an assistant professor for academic institutions or equivalent for non-academic research institutions. Note that postdoctoral fellows are ineligible.
Keywords: Behavioral Pharmacology, Behavioral Problems or Disorders, Brain Disorders, Clinical Research or Studies, Medical Technology, Mental Depression, Mental Health, Neuropsychiatry, Schizophrenia, Traumatology, Accidents & Injury
Suicide Prevention: Brief Interventions for Youth
Suicide rates in the US have been increasing during the past two decades, and there is concern that the economic, social, and psychological effects of the COVID 19 epidemic will lead to a further rise in suicide rates. Increasing rates for youth have caused specific concern. PCORI seeks to fund large randomized controlled trials (RCTs) and/or observational studies that respond to the following question: What is the comparative effectiveness of different brief interventions to reduce suicidality and improve outcomes for youth ages 15 to 24? Each proposed Brief Intervention must be clearly defined, evidence-based or in clinical use, and be, or be able to be made, widely available. Brief Interventions should be designed to reduce acute suicide risk and direct patients to appropriate treatment, and should be deliverable in a variety of settings and by a range of healthcare professionals. PCORI is particularly interested in the comparative effectiveness of culturally adapted approaches to brief interventions for specific populations. Such adaptations should address barriers to effective patient-centered care for these populations. Cultural adaptation may include involvement of people with lived experience, telehealth, cultural contexts, specific settings, or other cultural factors. Proposals should have strong endorsement and study participation by people with lived experience, patient organizations, professional organizations, payer or purchaser organizations, and/or other relevant stakeholder groups.
Application Dates: 29 Sep 2021, 12 Jan 2022 (Anticipated, this call is repeated once a year)
Amount Available: Maximum Project Budget (Direct Costs): $10 million. Maximum Research Project Period: 5 years
Eligibility: Academic Institution, Commercial or Private Sector, Government or Public Sector, Non-profit
Keywords: At-Risk Children or Youth, Suicides & Suicide Attempts
Sidney R. Baer, Jr. Foundation Grant
The Sidney R. Baer, Jr. Foundation is a catalyst for positive change in the lives of those living with schizophrenia and bipolar disorder. It is their mission to award grants to individuals, organizations, and institutions doing work that will have a tangible impact on the field of mental health. Their vision is a better world, where those afflicted with schizophrenia and bipolar disorder might no longer feel the isolation so often associated with the disease. Grant categories: Education, Criminal Justice, Reintegratio, Clinical Research, Social Support.
*Anticipated* Application Due Date: February 1, 2022
Amount Available: Previous years' grants have ranged from $4,000 to $1,267,950.
Eligibility: Qualifying organizations must have tax-exempt status under IRS sections 501(c)(3) and 509(a)(1) or 509(a)(2).
Funding Website:
Keywords: Affective Disorders, Mental Health, Schizophrenia
1907 Trailblazer Award Research
The 1907 Trailblazer Award was established to encourage high-impact, step-change approaches to research in the brain and mind sciences for mental health. In addition to supporting a specific research project, the Award intends to increase the size of the talent pool of early career investigators researching causes; cures for mental illness. Projects must be grounded in the study of biological mechanisms underlying brain function, cognitive processes, and/or consciousness. We support projects for basic science in addition to near-term applications (e.g. disruptive technologies and potential clinical interventions). *Limited submission** Each university/research institution may select up to two candidates.
**Anticipated** Application Due Date (s): June 15, 2022 (LOI) | June 30, 2022 (Full Proposal)
Sponsor: 1907 Research
Amount Available: $120,000
Eligibility: This award is open to all universities/research institutions in the US, the UK, or Canada. Applicants must be within ten years of the date when PhD/MD degree awarded.
Keywords: Clinical Psychology, Cognitive Psychology, Genetics, Mental Health, Neuroimaging, Neurological Disorders, Neurology, Neuroscience, Psychiatry, Psychology
AACAP Junior Investigator Award
The AACAP Junior Investigator Award, supported by AACAP and Industry Sponsors, offers an award for a child and adolescent psychiatry early career faculty (assistant professor level or equivalent). The program is intended to facilitate innovative research. The research may be basic or clinical in nature but must be relevant to our understanding, treatment and prevention of child and adolescent mental health disorders.
Deadline: 01 Apr 2022 (Application) - Anticipated, this call is repeated once a year.
Amount: The award is up to $30,000 a year for two years Recipients are required to submit a poster presentation on his or her research for AACAP's Annual Meeting in New York, New York
Eligibility:
Keywords: Child or Adolescent Mental Health, Child Psychiatry, Clinical Research or Studies, Mental Disorders, Psychiatry
* * * * *
AACAP Marilyn B. Benoit, MD, Child Maltreatment Mentorship Award
The AACAP Marilyn B. Benoit, MD, Child Maltreatment Mentorship Award seeks to provide an experiential opportunity for child and adolescent psychiatry residents, child and adolescent psychiatry (CAP) fellows, or early career psychiatrists (ECPs) who show interest in the fields of child welfare, foster care, and/or child maltreatment prevention/intervention. Under the supervision of an experienced mentor, each awardee will collaborate and design a project that will raise awareness and interest in these subject areas.
Deadline: 16 Apr 2022 (Application) - Anticipated, this call is repeated once a year.
Amount: Upper: $8,000USD, Length of Program: 12 to 16 Weeks
Eligibility:
Keywords: Child Abuse & Neglect, Child or Adolescent Mental Health, Child Psychiatry, Child Welfare, Foster Care
* * * * *
AACAP Pilot Research Award for Attention Disorders
The AACAP Pilot Research Award for Attention Disorders, supported by the Elaine Schlosser Lewis Fund, offers funds to child and adolescent psychiatry fellows and early career faculty who have an interest in beginning a career in child and adolescent psychiatry research. By providing awards to a child and adolescent psychiatry early career faculty member or fellow for pilot research on psychiatric conditions that involve attentional dysfunction, we support young investigators at a critical stage, encouraging a future career in child and adolescent psychiatry research. More info...
Deadline: 01 Apr 2022 (Application) - Anticipated, this call is repeated once a year.
Amount: Upper: $15,000USD. The recipient has the opportunity to submit a poster presentation on his or her research for AACAP’s Annual Meeting in Toronto, Ontario, Canada. The award also includes travel support to attend the AACAP Annual Meeting for up to five days.
Keywords: Attention Deficit Disorder, Child or Adolescent Mental Health, Child Psychiatry, Psychiatry
* * * * *
AACAP Pilot Research Award for Early Career Faculty and Child and Adolescent Psychiatry Fellows
The AACAP Pilot Research Award for Early Career Faculty and Child and Adolescent Psychiatry Fellows offers funds for child and adolescent psychiatry fellows and early career faculty who have an interest in beginning a career in child and adolescent psychiatry research.
Deadline: 01 Apr 2022 (Application) - Anticipated, this call is repeated once a year.
Amount: Upper: $15,000USD. Recipients have the opportunity to submit a poster presentation on their research for AACAP’s 69th Annual Meeting in Toronto, Ontario, Canada, October 17-22, 2022. The award also includes travel support to attend AACAP’s Annual Meeting for up to five days.
Eligibility:
Keywords: Child or Adolescent Mental Health, Child Psychiatry
* * * * *
Life Members Mentorship Grants for Medical Students
The AACAP Life Members Mentorship Grants for Medical Students (MGMS) provides the opportunity for medical students to attend the 68th AACAP Annual Meeting, October 15 - October 30, 2021, and receive an introduction into the field of child and adolescent psychiatry through AACAP’s Annual Meeting mentorshsip events. The MGMS recipients program requirements include participating in programs sponsored by the Life Members, a group of the oldest and most distinguished members of AACAP, all having been members for at least 30 years. Many of those in this group served as AACAP leadership and also pioneered many of the significant discoveries and developments in the field of child and adolescent psychiatry. In collaboration with the Committee on Medical Students and Residents, this program provides participants with networking opportunities, exposure to varying specialties, and interaction with Life Members.
Deadline: 02 Jul 2022 (Application) - Anticipated, this call is repeated once a year.
Amount: Up to $1,000 reimbursement for expenses to 68th AACAP Annual Meeting.. This includes airfare, hotel, in-transit costs, and meals (max. $75/day). Applicants will be required to provide documentation of travel expenses.
Eligibility:
Keywords: Adolescents, Child or Adolescent Mental Health, Child Psychiatry
Alzheimer's Association Research Grants to Promote Diversity
New to the Field (AARG-D-NTF)
Research Grant to Promote Diversity (AARG-D)
The Alzheimer's Association Research Grant to Promote Diversity (AARG-D) award is up to increase the number of scientists from underrepresented groups at academic institutions in Alzheimer's and other dementias research.
Important Dates (Anticipated, this call is repeated once a year):
Amount Available: Each AARG-D award is limited to $150,000 (direct and indirect costs) for up to three years (minimum two years).
Eligibility: Applicants must be Assistant Professors or above at their respective institution. For individuals who are at non-academic institutions, please contact the Alzheimer's Association to verify your eligibility.
Keywords: Alzheimers Disease, Behavioral or Social Studies, Clinical Research or Studies, Dementia, Neurodegenerative Diseases, Parkinsons Disease
Kempf Award for Research Development in Psychobiological Psychiatry
The Kempf Fund Award for Research Development in Psychobiological Psychiatry, established in 1988, recognizes a senior researcher who has made a significant contribution to research on the causes and treatment of schizophrenia as both a researcher and a mentor. An award is also made to support the career development of a young research psychiatrist working in a mentor-trainee relationship with the award winner. Funded by the estate of Dorothy C. Kempf.
Application Due Date (s): September 30, 2021
Amount Available: $1,500 & $20,000. Award includes: $1,500 to the senior researcher awardee, $20,000 to the awardee. Engraved Plaque.
Eligibility: The senior researcher and young research psychiatrist must be: Psychiatrists, Citizens or Permanent Residents of the U.S. or Canada
Keywords: Psychiatry, Psychobiology
Biomarker Development/Validation (CReATe)
TheCReATeConsortium, a NIH-funded Rare Diseases Clinical Research Consortium, in partnership with the ALS Association, is pleased to announce this request for applications (RFA) to support the discovery and/or validation of biomarkers for ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]). Priority will be given to those projects that are focused on developing biomarkers of disease mechanism and that might be relevant to the development of therapies. Proposals to developeitherwet(e.g. biofluidbased) ordry (e.g. neuroimaging, neurophysiological) biomarkers are encouraged. Investigators submitting an application in response to this RFA may also request to use the data and/or biological samples collected by the CReATe Consortium.
Amount Available: up to $60,000, 1-year
Application Due Date (s): May, 07 2022 (LOI) | July 30, 2022 (Full Proposal)
Eligibility: Any individual with the requisite scientific training, irrespective of country of residence or origin, may submit an application in response to this RFA.
Keywords: Amyotrophic Lateral Sclerosis, Biological Markers & Sensor Mechanisms, Neurodegenerative Diseases, Neuroimaging, Neurophysiology, Orphan Rare Diseases
The APA Distinguished Scientific Awards for an Early Career Contribution to Psychology honor early career scientists for contributions in the first 9 years post-PhD. For the purpose of this award, psychology has been divided into 10 areas: animal learning and behavior, comparative developmental, health cognition/human learning, psychopathology, behavioral and cognitive neuroscience, perception and motor performance, social psychology, applied research (e.g., treatment and prevention research, industrial/organizational research, educational research), individual differences (e.g., personality, psychometrics, mental ability, behavioral genetics). Five areas are considered each year, with areas rotated in 2-year cycles.
Application Due Date (s): 01 Jun 2022 - Anticipated / sponsor
Amount Available: not specified
Eligibility: For the 2022 program, nominations of persons who received doctoral degrees during and since 2012.
Keywords: Animal Behavior or Ethology, Applied Sciences, Cognitive Development or Processes, Genetics, Human Learning and Memory, Neuroscience, Psychology, Psychopathology, Quantitative Psychology, Social Sciences, Visual Perception
Donald B. Lindsley Prize in Behavioral Neuroscience
The Donald B. Lindsley Prize in Behavioral Neuroscience, endowed by The Grass Foundation, recognizes a young neuroscientist's outstanding PhD thesis in the general area of behavioral neuroscience.
Amount: Recipients receive a $5,000 prize and complimentary registration, transportation (economy air or ground), and two nights hotel accommodations for the SfN annual meeting. The SfN president presents the prize at a lecture at the meeting.
Swartz Prize for Theoretical and Computational Neuroscience
The Swartz Prize, endowed by the Swartz Foundation, honors an individual whose activities have produced a significant cumulative contribution to theoretical models or computational methods in neuroscience or who has made a particularly noteworthy recent advance in theoretical or computational neuroscience.
Amount: Recipients receive a $30,000 prize and complimentary registration, transportation (economy air or ground), and two nights hotel accommodations for the SfN annual meeting. The SfN president presents the prize at a lecture at the SfN annual meeting
Deadline: 14 May 2022 (Nominations for both) - Anticipated, this call is repeated once a year.
Eligibility:
Keywords: Computational Neuroscience, Neuroscience
Alzheimer's Association Clinician Scientist Fellowship to Promote Diversity
AACSF-D Award
Fellowship to support exceptional clinician scientists who are currently underrepresented at academic institutions in clinical research training in Alzheimer's and all dementias. Amount up to $155,000-175,000USD
Eligibility: Individuals who are early in their clinician scientist careers will be given priority. Minority only.
Persons with Disabilities only
Alzheimer's Association Research Fellowship
AARF Award
This fellowship is intended to support exceptional researchers who are engaged in their post-graduate work (i.e., postdoctoral fellows) and before they have their first independent faculty positions (i.e., Assistant Professor) and working in diverse areas of research, including basic, translational, clinical, functional and social-behavioral research. Amount up to $175,000, 2-3 years
Alzheimer's Association Research Fellowship to Promote Diversity
AARF-D Award
This fellowship is intended to support exceptional scientist from underrepresented groups working in Alzheimer's and all other dementia research, and who are engaged in their post-graduate work (i.e. postdoctoral fellows) and before they have their first independent faculty positions (i.e. Assistant Professor) and working in diverse areas of research including basic, translational, clinical, functional and social-behavioral research. Amount up to $175,000, 2-3 years
*Anticipated* Important Date (s):
Eligibility: Individuals applying to the AARF program will be accepted from postdoctoral fellows with full-time positions at their respective institution who have less than 10 years of research experience after receipt of their terminal degree. Individuals who have a position of an Assistant Professorship or above are not eligible. For individuals who are at non-academic institutions, please contact the Alzheimer's Association to verify your eligibility.
Keywords: Alzheimers Disease, Behavioral Medicine, Clinical Research or Studies, Clinical Trials, Dementia, Health Services Delivers, Neurological Disorders, Outcomes Research (Medical)
AACAP Pilot Research Award for General Psychiatry Residents
The AACAP Pilot Research Award, supported by Industry Sponsors offers funds for general psychiatry residents who have an interest in beginning a career in child and adolescent psychiatry research. By providing awards to general psychiatry residents for pilot research programs, we support these young investigators at a critical stage, encouraging future careers in child and adolescent psychiatry research. Amount: $15,000
AACAP Pilot Research Award for Learning Disabilities
The AACAP Pilot Research Award for Learning Disabilities, supported by AACAP's Elaine Schlosser Lewis Fund, offers funds for child and adolescent psychiatry fellows and early career faculty who have an interest in beginning a career in child and adolescent psychiatry research. By providing awards to a child and adolescent psychiatry early career faculty member or fellow for pilot research on psychiatric conditions that involve learning dysfunction, we support a young investigator at a critical stage, encouraging a future career in child and adolescent psychiatry research. Amount: $15,000
Deadline: 01 Apr 2022 - (Application) Anticipated / sponsor
Eligibility: Individuals: Early Career and Emerging in Field
* * * * *
Jeanne Spurlock Research Fellowship in Substance Abuse and Addiction for Minority Medical Students
The AACAP Jeanne Spurlock, MD, Research Fellowship in Substance Abuse and Addiction offers a unique opportunity for minority medical students, or students whose project will focus on minorities, to explore a research career in substance abuse in relation to child and adolescent psychiatry, gain valuable work experience, and meet leaders in the child and adolescent psychiatry field. Amount: $4,000
Summer Medical Student Fellowship in Child and Adolescent Psychiatry
The AACAP Summer Medical Student Fellowships offer a chance for medical students to explore a career in child and adolescent psychiatry, gain valuable work experience, and meet leaders in the child and adolescent psychiatry field. Amount: $3,500 US
Deadline: 01 Mar 2022 - (Application) Anticipated / sponsor
Eligibility: Individuals: Graduate Student or Pre-doc
* * * * *
Keywords: Child or Adolescent Mental Health, Child Psychiatry, Psychiatry, Attention Deficit Disorder, Learning Disorders, Addictions, Adolescents, Drug Abuse Treatment, Drugs or Drug Abuse, Health of Underserved Populations, Minorities and Disadvantaged, Minority Health, Substance Abuse
American Association of Neurological Surgeons (AANS)
NREF Research Fellowships and Young Clinician Investigator Awards
As a premier funder of neurosurgical studies, the Neurosurgery Research & Education Foundation(NREF) focuses on providing fellowship funding in basic neuroscience and neurosurgical programs in North America.
Research Fellowship (RF) - The Fellowship provides training for neurosurgeons who are preparing for academic careers as clinician investigators. 100% of the applicant's research efforts must be devoted to this project. Eligibility: Applicants must be physicians who have been accepted into, or who are currently in approved residency training programs in neurological surgery in North America. U.S. Citizenship is not required to apply.
Young Clinician Investigator (YCI) Award - supports junior faculty who are pursuing careers as clinical investigators. 50% of the applicant's research efforts must be devoted to this project. Eligibility: Applicants must be neurosurgeons, no more than two years from having completed their neurosurgical residency training, and/or clinical fellowship, who are full-time faculty in North American teaching institutions. U.S. Citizenship is not required to apply.
Amount: $50,000USD. Research Fellowship Grant (One year; up to $50,000). Young Clinician Investigator Award (One year; up to $50,000)
Deadline: 01 Nov 2021 - (Application) This call is repeated once a year.
Keywords: Clinical Research or Studies, Neuroscience, Neurosurgery
* * * * *
William P. Van Wagenen Fellowship
The Van Wagenen Fellowship was designed to give freedom in scientific development without the restrictive limitations usually imposed by many research grants and fellowships. The AANS offers the Van Wagenen Fellowship program to neurosurgical residents interested in studying scientific development abroad. The fellowship is open to all senior neurological residents (PGY5, PGY6 & PGY7) in approved neurosurgery residency programs and whose intent is to pursue an academic career in neurological surgery.
Amount: Upper: $120,000USD. The fellowship provides up to a $120,000 stipend for living and travel expenses to a foreign country for a period of twelve months; a $6,000 stipend for family travel and living allowance is available if the spouse and/or children are accompanying the fellow; and $5,000 is available for medical insurance if needed. One award per year is typically given. The fellowship makes $15,000 of research support available to the university, hospital or laboratory, which has agreed to sponsor the Van Wagenen Fellow.
Deadline: 01 Oct 2022 (Application) Anticpated, this call is repeated once a year.
Eligibility: The fellowship is open to all senior neurosurgical residents (PGY5, PGY6 & PGY7) in approved neurosurgery residency programs whose intent is to pursue an academic career in neurological surgery. United States citizenship is not a requirement. The country of study must be different than the country of residence.
Keywords: Medical Education, Neurology, Neurosurgery
AFSP Postdoctoral Research Fellowship Innovation Grants
Postdoctoral Research Fellowships are training grants designed to enable young investigators to qualify for independent careers in suicide research. The training can be in either basic or clinical research and must be full-time; that is, Fellows are expected to devote at least 40 hours per week to the training program and may not have any significant clinical or other responsibilities during the funding period. Survey data suggests that individuals who are LGBT are at greater risk for suicide attempts (Haas, Eliason et al. 2011). However, confirmation of this finding is needed across a wider range of samples and using a wider range of data collection methods. In an effort to learn more about this issue we suggest that all AFSP-funded researchers who are collecting original data systematically assess research participants for sexual orientation and gender identity.
Amount: Up to $120,000 over 2 years (Salary of $50,000 per year. Allowance of $10,000 per year.)
Eligibility: Grants awarded to investigators who have received a Ph.D., M.D., or other doctoral degree within the preceding six years and have had no more than three years of fellowship support.
Important Date(s): November 15, 2021 (Application)
Keywords: Anxiety Disorders, Drug Abuse Prevention, Drug Abuse Treatment, LGBTQ Studies, Mental Health, Outcomes Research (Medical), Patient Care Planning, Preventive Medicine, Sexuality and Sex Roles, Suicides & Suicide Attempts
Predoctoral Fellowship
The purpose of the fellowship is to enhance the integrated research and clinical training of promising students who are matriculated in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists, or related careers aimed at improving global cardiovascular, cerebrovascular and brain health.
Deadline: 01 Dec 2021 (Application) - Anticipated, this call is repeated once a year.
Award: $32,036 - $64,072, 1-2 years
Eligibility: Full-time students working towards his/her degree and are enrolled in a post-baccalaureate PhD, MD, DO, DVM, PharmD, DDS, DrPH, or PhD in nursing or equivalent clinical health science doctoral degree program, who seeks research training with a sponsor prior to embarking upon a research career
Keywords: Brain Disorders, Cardiovascular Disease, Stroke & Cerebrovascular Disorders
Child and Adolescent Psychiatry Fellowship
Fellowship is designed to develop and enhance interest among general psychiatry residents in pursuing careers in child and adolescent psychiatry and to foster child and adolescent psychiatrists’ active involvement in the APA and APAF. This two-year fellowship program provides residents with opportunities to attend and Participate in APA Annual meetings and mentoring activities with senior psychiatrists and leaders in the field. SAMHSA Minority Fellowship
Supported by the Substance Abuse and Mental Health Services Administration (SAMHSA), the SAMHSA Minority Fellowship provides a one-year (2nd year optional) fellowship to psychiatry residents who are at the PG1 level or higher and are committed to addressing minority psychiatric mental health issues.
Eligibility: PGY-1 level or higher at the time of matriculation. It is not required for applicants to identify as ethnic minorities; however, African Americans, Alaska Natives, American Indians, Asian-Americans, Hispanics/Latinos, Native Hawaiians, and Pacific Islanders are especially encouraged to apply.
Deadline: 31 Jan 2022 - Anticipated, this call is repeated once a year.
Amount: up to $28,000
Keywords: Behavioral Medicine, Behavioral or Social Studies, Cognitive Science, Cross Cultural Studies, Mental Health Services, Minority Health, Minority Mental Health, Psychiatry, Social Sciences, At-Risk Children or Youth, Child or Adolescent Mental Health Child Psychiatry
APsaA Fellowship Program
The American Psychoanalytic Association founded its Fellowship Program in 1991.
Award Amount: All applicants will have their registration fee waived for the National and Annual meetings following the application deadline. The first meeting for which they can receive complimentary registration takes place in June; the second, in February. Fellows will have their expenses (including travel, lodging, food, and meeting registration fee) covered for the meetings of the American Psychoanalytic Association that take place during their fellowship year (February and June). Fellows may also receive gifts of books from various publishers. Fellows will receive:
Eligibility: Early-career academics/multidisciplinary scholars, licensed mental health counselors, marriage and family therapists, psychiatric nurse practitioners, psychiatrists, psychologists, and social workers are encouraged to apply. Individuals: Early Career and Emerging in Field. Individuals: Graduate Student or Pre-doc
Deadline: 01 Feb 2022, Application - Anticipated, this call is repeated once a year.
Keywords: Clinical Psychology, Clinical Research or Studies, Mental Health, Psychiatry, Psychoanalysis, Psychology, Social Work
Milton Safenowitz Postdoctoral Fellowship
The ALS Association is proud to support the development of new scientists through the Milton Safenowitz Postdoctoral Fellowship. These awards are to encourage and facilitate promising young scientists to enter the ALS field. Fellows work with a senior mentor and receive extensive exposure to the ALS research community through meetings and presentations. Topics of Interest (Scope): We are especially interested in Fellowships supporting the following: Studies for new target validation including in animal models, and human cell models. Studies that would elucidate target or pathway biology in disease-relevant models, including defining upstream/downstream modifiers and convergence of promising target pathways. Studies of risk factors that could ultimately reduce the risk of developing ALS including studies of genetic risk factors, epigenetics, gene-environment interactions, lifestyle, occupational or dietary factors and epidemiology. Studies of new biomarker identification, and development and/or validation of biomarker assays. Studies to help people living with ALS, including development and/or validation of novel assistive technology and measurement of patient/caregiver/family burden.
Application Due Date (s): April 23, 2022
Amount Available: $150,000 USD total, project time two years
Eligibility: Individuals who have the skills, knowledge, and resources necessary to carry out the proposed research and have an existing postdoctoral fellowship, including the support of their mentor. Applicants who have been fellows for less than two years by the time the award starts are eligible to apply.
Keywords: Amyotrophic Lateral Sclerosis, Animal Models, Epidemiology, Epigenetics, Genetics, Neurodegenerative Diseases
Pre- and Postdoctoral Training Awards & Medical Student Gap Year Research Training Awards
The Autism Science Foundation invites applications for its Pre-and Postdoctoral Training Awards from graduate students, medical students and postdoctoral fellows interested in pursuing careers in basic and clinical research relevant to autism spectrum disorders. The proposed training should be scientifically linked to autism but may be broadened to include training in a closely related area of scientific research. Autism Science Foundation will consider all areas of related basic and clinical research including but not limited to: human behavior across the lifespan (language,learning, behavior, communication, social function, motor skills; planning, epilepsy, sleep, repetitive disorders), neurobiology (anatomy, development, neuroimaging), pharmacology, behavioral intervention,neuropathology, genetics and gene/environment interactions, epigenetics, genomics, epigenomics,immunology, molecular and cellular mechanisms, studies employing model organisms and systems, and studies of treatment and service delivery, and dissemination of research findings. Special consideration will be given to projects focusing on traditionally under-researched populations, medical comorbidities of autism, a genetically-defined subtype of autism, and studies of families with a high probability of receiving a diagnosis.
Application Due Date (s): December 2, 2021
Amount Available: Foundation will make a number of awards determined by its available financial resources. The term of the award will be a period of one year and will include: For predoctoral and medical students: $25,000. For postdoctoral students: $35,000. This award cannot be used to cover tuition payments. No portion of these funds shall be used to cover indirect university costs.
Eligibility: Applicants for predoctoral awards must be enrolled students in good standing in a program leading to a research doctorate such as a Ph.D. or Sc.D. or a dual degree such as an M.D./Ph.D. in an academic department at an accredited university or health/medical institution. Applicants for Medical School Gap Year Research Training Awards should be enrolled at an accredited university medical school. Medical school applicants must apply prior to graduation from medical school but the gap year may be taken immediately after graduation.
Keywords: Autism, Behavioral Pharmacology, Clinical Research or Studies, Epigenetics, Epilepsy, Genetics, Genomics, Immunology, Medical Treatment, Neuroanatomy, Neurobiology, Neuropathology, Pharmacy & Pharmacology, Sleep & Sleep Disorders
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
RFA-NS-19-043
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)
RFA-NS-19-044
The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds in BRAIN Initiative research areas.
Amount Available: The BRAIN Initiative intends to commit $4.0M per year in fiscal years 2020-2023 to fund an estimate of 20 awards per year. Award budgets are composed of salary and other program-related expenses, as described below. The total project period may not exceed 5 years.
Important Dates: October 6, 2021 (New Applications), February 10, 2022 (New Applications)
* * * * *
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32).
RFA-MH-20-620
The purpose of the The Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates, early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative.
Amount Available: The BRAIN Initiative intends to commit up to $1.5 M per year in fiscal years 2021-2023 to fund an estimate of 20 awards per year. Individuals may receive up to 5 years of aggregate Kirschstein-NRSA support at the Award budgets are composed of stipends, tuition and fees, and institutional allowance, as described below. Individuals may receive up to 5 years of aggregate Kirschstein-NRSA support at the predoctoral level (up to 6 years for dual degree training, e.g., MD/PhD), and up to 3 years of aggregate Kirschstein-NRSA support at the postdoctoral level, including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award.
Important Date (s): 11 Mar 2022 (LOI), 11 Apr 2022 (Application)
* * * * *
Eligibility: Higher Education Institutions / Nonprofits Other Than Institutions of Higher Education / For-Profit Organizations / Governments / Other: Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations (other than Federally recognized tribal governments), Faith-based or Community-based Organizations, Regional Organizations, Public/State Controlled Institutions of Higher Education, Private Institutions of Higher Education.
Keywords: Neuroscience, Brain, Brain Disorders, Medical Education, Medical Ethics, Neuroimaging, Neurological Disorders, Neurology, Neurons, Neurophysiology, Neuroscience
Columbia University Department of Psychiatry
Alexander F. Bodini Fellowship in Developmental and Adolescent Psychiatry at the Italian Academy for Advanced Studies in America
The Alexander Bodini Fellowship in Psychiatry is intended for a child psychiatrist or developmental neuroscientist who intends to work in a Columbia laboratory in fields pertinent to his or her own. Relevant Columbia University resources include a large and varied Department of Child Psychiatry at the College of Physicians & Surgeons, with its far-reaching clinical service that is organized into subspecialty clinics serving children and teens with autism, depression and anxiety and disruptive disorders, and an outstanding MRI laboratory. Other areas of strength are psychiatric epidemiology; psychotherapy research and especially cognitive behavior therapy for anxiety disorders and interpersonal therapy for mood disorders; psychopharmacology of anxiety, depression and autism and early onset ADHD; classification and diagnosis; suicide and suicide prevention; eating disorders; and services research. The Department of General Psychiatry has considerable resources in genetics, in psychosis, depression and anxiety disorders, PET imaging and neuroanatomy.
Deadline: 02 Dec 2021 (Application) Anticipated, this call is repeated once a year.
Amount: Fellows receive a stipend, health benefits, travel allowance, and an office in the Academy on the Columbia University campus. Bodini Fellows spend one or two academic semesters in residence at the Italian Academy.
Eligibility: Applications are encouraged from all countries. Candidates must be at the post-doctoral or faculty level.
Keywords: Adolescent Psychology, Anxiety Disorders, Attention Deficit Disorder, Autism, Behavioral Problems or Disorders, Child Psychiatry, Developmental Psychology, Eating Disorders, Mental Depression, Psychiatry, Suicides & Suicide Attempts.
* * * * *
Fellowship in Substance Use Disorders
The Division on Substance Use Disorders sponsors a two-year postdoctoral training program for clinical/translational research careers in substance use disorders. This unique, integrated training program is designed for physician scientists and basic scientists from a variety of disciplines from basic to applied biological, psychological and social and public health areas. More information on Fellowship in Substance Use Disorders.
Deadline: 01 Oct 2021 - Applications will be accepted starting July 1 through October 1 in order to start the fellowship the following July 1. This call is repeated once a year.
Eligibility: Applicants must have an M.D. with relevant research experiences or a Ph.D. in psychology, neuroscience, policy health, or a related field.
Keywords: Addictions Behavioral Pharmacology, Biological Markers & Sensor Mechanisms, Clinical Research or Studies, Epidemiology, Medical Genetics, Neurobiology, Neuroimaging, Substance Abuse Prevention, Substance Abuse Treatment
* * * * *
Geriatric Psychiatry Research Fellowship
This is a two- to three-year fellowship in clinical and basic research on the psychiatric disorders of older adults, including Alzheimer's Disease, late-life depression, late-life anxiety disorders, and late-life psychosis. It is supported by a NIMH grant, and offers didactic methodological and statistical training as well as a supervised research experience.
Amount: There are four positions in the fellowship. One to two new fellows enter each year.
Deadline: 31 Dec 2021 (Application) - Confirmed, this call is repeated once a year.
Eligibility: U.S. citizen or permanent resident. M.D. with completed psychiatric or neurological residency, or PhD
Keywords: Alzheimers Disease, Anxiety Disorders, Clinical Research or Studies, Geriatric Mental Health, Mental Depression, Psychiatry, Psychosis.
* * * * *
Janssen Fellowship In Translational Neuroscience Research
The Paul Janssen Fellowship is awarded by the Department of Psychiatry at Columbia University to an outstanding young physician-investigator to conduct novel translational research in the field of neuroscience as it relates to psychiatric disease and medicine. The Paul Janssen Fellow will be assigned both a basic scientist mentor and a clinical investigator mentor from the faculty at Columbia University to serve as joint mentors. The fellow will take a basic observation made by the basic science mentor and apply it to the study of disease or treatment with the clinical research mentor.
Application Due Date (s): November 9, 2021.
Amount Available: The award provides a stipend, commensurate with experience. The stipend provided may require supplemental funding by the mentors.
Eligibility: Candidates from the international neuroscience community, holding an M.D. or Ph.D. degree, and preferably having completed initial fellowship research training, are invited to apply. Fellows at Columbia University or the New York State Psychiatric Institute/RFMH are encouraged to submit applications. **Faculty are not eligible.
Keywords: Neuropsychiatry Neuroscience
* * * * *
Fellowship in Schizophrenia Research
Department of Psychiatry, Columbia University fellowship focuses on research strategies, basic and clinical, related to schizophrenia and psychotic disorders. Supervised research, training in statistics and research methodology, and didactic seminars on schizophrenia comprise the two- to three-year program, which is supported by a National Institute of Mental Health (NIMH) grant.
Application Due Date (s): November 30, 2021.
Amount Available: There are six positions in the fellowship. Two to three new fellows enter each year.
Eligibility: MD preferably with completed psychiatric or neurological residency, or PhD with research experience in this area. U.S. citizen or permanent resident.
Keywords: Clinical Research or Studies, Mental Health, Psychiatry, Schizophrenia
Ruth K Broad Foundation Extramural Award
The Foundation funds research proposals advancing understanding of neurodegenerative disorders, with particular interest in the potential relationship to Alzheimer's disease. The research proposed should be an innovative direction of study for the applicant's lab with the potential for high impact on the field.
Deadline: 01 Feb 2022 (Application) - Anticipated, this call is repeated once a year.
Amount Available: $250,000 USD. The Foundation will be awarding a two-year grant (July 1, 2022-June 30, 2024) for $125,000 each year
Eligibility: Young or established non-Duke University investigators proposing new or novel research are eligible to apply
Keywords: Alzheimers Disease, Clinical Medicine, Clinical Research or Studies, Neurodegenerative Diseases, Neuroscience
Donald J. Cohen Fellowship in Developmental Social Neuroscience
The Donald J. Cohen Fellowship in Developmental Social Neuroscience provides recent college graduates with the opportunity to spend two years engaged in state-of-the-art clinical and basic research with children and families affected by autism spectrum disorders (ASD). Cohen Fellows are directly mentored by the program directors and are involved in a highly active and productive community of clinical research scientists who study ASD. Previous Cohen Fellows have led a wide range of research projects and have gone on to PhD, MD, and MD/PhD programs in both clinical, developmental, and basic science specialties.
Simons Fellowship in Computational Neuroscience
The Simons Fellowship in Computational Neuroscience provides recent college graduates with the opportunity to spend two years using computer programming and basic science to advance our understanding of autism spectrum disorders (ASD). Simons Fellows are directly mentored by the program directors and are involved in a highly active and productive community of clinicians, scientists, and engineers who study ASD. Previous Simons Fellows have led a wide range of research projects and have gone on to PhD, MD, and MD/PhD programs as well as to research positions in computer and software engineering.
Deadline: 08 Jan 2022 (Application) - Anticipated, this call is repeated once a year.
Amount: $34,000 per year (with full healthcare coverage), 2 years
Eligibility: College graduates who will have received a bachelor's degree by July 2021 are eligible to apply.
Keywords: Applied Sciences, Autism, Child or Adolescent Mental Health, Child or Maternal Health, Clinical Research or Studies, Developmental Neurobiology, Human Development, Social Development, Autism, Computational Neuroscience, Data Management or Analysis (Medical), Medical Diagnosis, Neuroscience
Harvard Medical School- Dean's Postdoctoral Fellowship
The Dean's Postdoctoral Fellowship (DPF) is a two-year research fellowship that was established in 2012 to nurture, advance, and retain a diverse scientific workforce who will continue to contribute to diversity through their ongoing academic and research scholarship. The fellowship program prepares scientists from groups historically underrepresented in the basic and social sciences for careers in academia and other sectors. Fellows benefit from a highly innovative and creative research environment that emphasizes scientific rigor, collaboration, and the pursuit of excellence in science. Fellows can choose to conduct research with faculty within the basic and social science departments in research programs or faculty labs.
Important Dates (s): 15 Apr 2022 - Anticipated / sponsor Applications will be accepted starting January 1, 2021.
Amount Available: up to $100,000 USD. The two-year fellowship provides funding in the amount of $50,000/year, and DPF fellows are eligible for Harvard's generous benefits package. They receive additional opportunities for career enhancement, mentorship, seminars, workshops, and conferences, along with a robust support network, through the Scholars in Translational and Academic Research (STARs) program.
Eligibility: Have completed an MD, MD/PhD, PhD, ScD, or equivalent in the basic or social sciences. Be a United States citizen or permanent resident ("green card"). Be from a group that is historically underrepresented in the basic and social sciences
Keywords: Cell & Developmental Biology, General Science and Technology Topics, Genetics, Global Health, Health Care Planning or Policy, Immunobiology, Medical Informatics, Microbiology, Minority Education, Neurobiology, Social Medicine, Social Sciences, Stem Cells, Systems Biology
* * * * *
Mind Brain Behavior Interfaculty Initiative - Postdoctoral Fellow Award
This two-year award is intended to fund a postdoctoral fellow (in accordance with NIH stipend guidelines) who wants to examine MBB-related issues through interdisciplinary research and experiences.
Important Dates (s): March 5, 2022 (Application)
Amount: Amount Note: Note that funding for the second year is conditional upon satisfactory progress at the completion of the first year. Funds are intended to support projects that coincide with Harvard's fiscal year: i.e. July 1, 2021 to June 30, 2023.
Eligibility: Ph.D., M.D. or M.D./Ph.D. in an MBB-related field and no more than 1 year of postdoctoral experience. Research project must bridge at least two classical fields of study.
Keywords: Behavioral Biology, Behavioral or Social Studies, Brain, Brain Disorders
Research Initiatives: Basic Research Grants Program and Fellowships
The Hereditary Disease Foundation provides funding for research that advances the discovery and development of treatments for Huntington’s disease and other brain disorders. We are passionate about finding and funding the most innovative, creative and paradigm-changing research possible. The data generated with HDF funding often allows researchers to get initial findings that help them apply successfully for larger, long-term funding from other funding agencies, including the National Institutes of Health.
The Foundation’s current focus is on 1) modifier studies - on DNA repair pathways, protein degradation and other modifiers of phenotype and age of onset; 2) mechanisms of HD neurodegeneration; 3) biomarkers of disease progression; and 4) therapy for HD-induced neurodegeneration. Types of Funding:
The Basic Research Grants Program: Supports projects contributing to identifying and understanding the fundamental defects in Huntington’s disease.
Postdoctoral Fellowships: These postdoctoral fellowships are intended to cultivate interest in Huntington’s disease research by bright young scientists. Fellowships are granted to those who possess imagination, rigor, creativity and spirit to push forward toward a cure for HD and ensure that these discoveries can be applied to other brain diseases.
Deadlines: 01 Feb 2022 (LOI), 16 Apr 2022 (Application) - Anticipated, this call is repeated once a year. NOTE: Letters of Intent will not be accepted prior to Dec 15.
Award Amount: up to $75,000
Eligibility: The HDF funds research grants and postdoctoral fellowships at the post-graduate level. HDF grant and fellowship applicants must present a specific research plan.
Keywords: Biological Markers & Sensor Mechanisms, Brain Disorders, DNA Repair, Genetic Disorders, Huntingtons Disease, Neurobiology, Neurodegenerative Diseases
Klingenstein-Simons Fellowship Awards in Neuroscience
The Klingenstein-Simons Fellowship supports early-career investigators engaged in basic or clinical research that may lead to a better understanding of neurological and psychiatric disorders. Several areas within neuroscience are of particular interest: Cellular and molecular neuroscience. Studies of the mechanisms of neuronal excitability and development, and of the genetic basis of behavior. Neural systems. Studies of the integrative function of the nervous system. Translational research. Studies designed to improve our understanding of the causes, prevention, diagnosis, and treatment of neurological and psychiatric disorders.
Application Due Date (s): February 15, 2022
Sponsoring Agency: Esther A. and Joseph Klingenstein Fund, Inc.
Amount Available: "$225,000 USD. The award of $225,000 is payable over a three-year period beginning July 1.
Eligibility: To qualify for an award, investigators must hold a Ph.D. and/or an M.D, and have completed all research training, including post-doctoral training. Candidates must also meet these four qualifications: The candidate must have a tenure track appointment or equivalent. A letter indicating the commitment of institutional resources to establish the investigator and the prospects for long-term support by the institution must be provided by an institutional official (e.g., dean), including date of appointment. The candidate must be an independent investigator at a university, medical center or research institute with no more than four years having passed since completing postdoctoral training and the start of his/her tenure track or equivalent appointment. U.S. citizenship is not a requirement, but it's expected that candidates will be permanent residents of the U.S. and their research will be conducted in U.S. institutions. Applicants must inform the EAJK Fund of other sources of funding. Although there's no strict prohibition against holding more than one fellowship at one time, the Fund may take other funding into account when deciding whether to grant an Award. Applications will be reviewed, and selections made, by a Scientific Advisory Committee of distinguished neuroscientists.
Keywords: Clinical Trials, Epilepsy, Nervous System, Neural Stimulation, Neurological Disorders, Neuroscience, Psychiatry
KTGF Fellowship Programs
The KTGF awards fellowship grants annually to outstanding post-doctoral candidates who are investigating the causes, prevention, and treatment of child and adolescent ADHD and depression, and access to mental health care. The Fellowship supports two-year research projects that could lead to federal funding and other national research awards. The Foundation wants this research to produce direct and tangible benefits to children and their families, while supporting promising young scientists in building their careers.
Important Dates (s): 30 Nov 2021 (Nomination), 10 Jan 2022 (Application). This call is repeated once a year.
Amount Available: $60,000USD, $30,000 per year. Two years total.
Eligibility: Department Chairs may nominate only one investigator for each of the three fellowship areas: ADHD, depression, and access to care. Candidates must hold a Ph.D. and/or M.D. and have completed all clinical training.
Keywords: Adolescent Psychology, Attention Deficit Disorder, Child or Adolescent Mental Health, Child Psychiatry, Child Psychology, Health Services Delivery, Mental Depression
Career Transition Fellowships
Finding a way to stop MS, restore function and end MS forever will require a cadre of well-trained scientists engaged in MS-related research. The Society's Career Transition Fellowship addresses this need by fostering the development and productivity of young scientists who have potential to make significant contributions to MS research and help ensure the future and stability of MS research. The Career Transition Fellowship targets current postdoctoral trainees who demonstrate both commitment and exceptional potential to conduct MS-related research.
Application Dates (s): May 05, 2022 , August 18 2022
Amount Available: The award provides approximately $550,000 over five years to support a two-year period of advanced postdoctoral training in MS research and the first three years of research support in a new faculty appointment.
Eligibility: Applicants must hold a doctoral degree (M.D., Ph.D. or equivalent) and must be in a research-oriented postdoctoral training program at an academic, government, or non-profit research institution. Individuals with less than two or more than five years of postdoctoral research experience at the time of application are ineligible for this award. Clinically related training periods such as medical residencies or sub-specialty fellowships will not be counted towards postdoctoral research experience. There are no citizenship requirements for individuals applying from U.S. institutions. However, individuals seeking support for advanced postdoctoral training at foreign institutions must be U.S. citizens.
Keywords: Multiple Sclerosis Neurological Disorders
Pediatric Rehabilitation Medicine (PRM) Fellowship
There is a balanced time commitment between outpatient, consulting, inpatient, research and education. The fellow is an integral part of the pediatric rehabilitation team at Shirley Ryan AbilityLab and has the advantage of drawing from multiple pediatric subspecialties in the Chicagoland area including Ann & Robert H. Lurie Children's Hospital of Chicago and Shriners Hospital for Children. Typical experiences include inpatient management of children with cerebral palsy, neuromuscular disorders, traumatic brain and spinal cord injuries, burn injuries, oncology-related impairments, and organ transplant.
Important Dates (s): 15 Dec 2021 (Application) - Anticipated, this call is repeated once a year.
Amount: The fellowship is accredited for 2 years following a PM&R residency and 1 year after a combined Pediatrics-PM&R residency.
Eligibility: This program is open only to individuals who have completed their medical residency program in North America.
Keywords: Burns, Cerebral Palsy, Community Health, Medical Education, Neuromuscular Diseases, Oncology, Organ Transplantation, Pediatrics, Rehabilitation or Therapy, Spinal Cord Injury, Traumatic Brain Injury
SOPHE/CDC Student Fellowship in Injury Prevention
The Student Fellowship in Injury Prevention is funded by the CDC's National Center for Injury Prevention and Control. The fellowship recognizes, assists and trains students working on research or practice-based projects in unintentional injury prevention from the perspective of health education or the behavioral sciences. Apply if your project is related to: drug overdose, transportation/motor vehicle related injury, older adult fall prevention, drowning, suicide, concussion/traumatic brain injury. This can include projects in surveillance and surveys, risk factor identification, educational and policy interventions, evaluations, replications, translation, economics, community promotion, dissemination research, communications.
Application Due Date (s): June 1, 2022
Amount Available: See website.
Eligibility: Applicants must be a full time student in a masters or doctoral degree program in health education, health promotion, behavioral sciences or a related field.
Keywords: Behavioral or Social Studies, Geriatrics & Gerontology, Injury Prevention, Public Health, Risk Factor Analysis, Substance Abuse, Transportation Safety, Traumatic Brain Injury
NRSA for Training of Postdoctoral Fellows
PAR-21-032 (F32 Clinical Trial Not Allowed)
The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support promising candidates during their mentored postdoctoral training under the guidance of outstanding faculty sponsors.
Important Date(s): October 14, 2021, Febuary 9, 2022
Award Amount: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Award budgets are composed of stipends, tuition and fees, and institutional allowance, as described below. Individuals may receive up to 3 years of aggregate Kirschstein-NRSA support at the postdoctoral level, including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award. For this FOA, support will be provided only during the first 4 years of postdoctoral experience in any one particular laboratory or research environment. For example, if an award is made 18 months after the start of the postdoctoral position in the fellowship laboratory or research environment, the award duration will be for a maximum of 30 months.
* * * * *
Individual Predoctoral Fellowship
PA-21-051 (Parent F31)
The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers.
Individual Senior Fellowship
PA-21-047 (Parent F33)
The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers.
Individual Postdoctoral Fellows
PA-21-048 (Parent F32)
The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship.
Important Date(s): December 8, 2021
Amount Available: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Award budgets are composed of stipends, tuition and fees, and institutional allowance, as described below. Individuals may receive up to 5 years of aggregate Kirschstein-NRSA support at the predoctoral level (up to 6 years for dual degree training, e.g., MD/PhD), and up to 3 years of aggregate Kirschstein-NRSA support at the postdoctoral level, including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award.
* * * * *
Eligibility: Higher Education Institutions / Nonprofits Other Than Institutions of Higher Education / For-Profit Organizations / Governments / Other: Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations (other than Federally recognized tribal governments), Faith-based or Community-based Organizations, Regional Organizations, Public/State Controlled Institutions of Higher Education, Private Institutions of Higher Education.
Keywords: Biomedical Research Training, Medical Education, Clinical Trials, Biomedical Research (Multidisciplinary), Health and Medicine, Biomedical Research (Multidisciplinary), Biomedical Research Training, Career Education and Planning
Simons Collaboration on the Global Brain (SCGB) Undergraduate Research Fellowship
SURF Program Website
The goal of the Simons Collaboration on the Global Brain (SCGB) Undergraduate Research Fellowship (SURF) Program is to spark and sustain interest in systems and computational neuroscience among undergraduate students from diverse backgrounds underrepresented in neuroscience research. SCGB is launching this program with the recognition that diversity improves scientific innovation and collaboration. SURF provides funds for undergraduate research assistants to work in SCGB-funded laboratories during the academic year under the mentorship of postdoctoral fellows or Ph.D. students to provide personalized guidance to undergraduates.
Deadline: 31 May 2022 (Application) Anticipated, Note: After review, SCGB will coordinate with labs to match selected candidates with available mentors. Applicants should be available to speak with possible matches between July 5 and July 23. Fellows will be informed of their matches by July 26 and allowed until August 2 to accept or decline.
Amount: $7,500 USD. Applicants must live within a reasonable commute of an available lab opportunity. Fellows will receive a commitment of $25 per hour wage for 10 hours per week over 30 weeks, administered through the hosting laboratory. Awards will begin in the fall academic semester. In addition to financial support, SCGB will provide program certificates to Fellows, facilitate meetings among Fellows and Mentors, and arrange an end-of-year research symposium for Fellows to share their work.
Eligibility: Applicants must be currently enrolled at a degree-granting undergraduate institution (including community colleges). It is not necessary for applicants to have prior laboratory experience.
Keywords: Computational Neuroscience, Minority Education, Neuroscience
Postdoctoral Fellowship Positions in Neuroimaging in Pain Research
Stanford University, Stanford Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Medicine: applicants should have (or anticipate having) a Ph.D. and research background in Cognitive Neuroscience, Neurophysiology, Neuropsychology, or related fields. Individuals with backgrounds in Electrical Engineering, Physics, Mathematics, Computer Science or similar fields and a strong interest/background in Psychology and human neuroimaging are also encouraged to apply. Applicants should be experienced at designing and implementing cognitive neuroscience experiments. Preferences given to candidates who have experience with conducting fMRI studies, working with MRI scanners, processing MRI and fMRI datasets, and running neuroimaging data analysis using software packages, such as Matlab, SPM, FSL E-Prime, and AFNI. Applicants should also possess strong interpersonal skills and be able to work independently with minimal supervision.
Application Due Date (s): Ongoing
Amount Available: Amount Note: Salary is commensurate with experience. The Division also has an NIH T32 that allows the candidate to apply for independent funding if desired.
Eligibility: Applicants should have (or anticipate having) a Ph.D. and research background in Cognitive Neuroscience, Neurophysiology, Neuropsychology, or related fields. Individuals with backgrounds in Electrical Engineering, Physics, Mathematics, Computer Science or similar fields and a strong interest/background in Psychology and human neuroimaging are also encouraged to apply. Applicants should be experienced at designing and implementing cognitive neuroscience experiments. Preferences given to candidates who have experience with conducting fMRI studies, working with MRI scanners, processing MRI and fMRI datasets, and running neuroimaging data analysis using software packages, such as Matlab, SPM, FSL E-Prime, and AFNI. Applicants should also possess strong interpersonal skills and be able to work independently with minimal supervision.
Keywords: Chronic Pain, Cognitive Science, Magnetic Resonance Imaging, Neuroimaging
* * * * *
Postdoctoral Fellowship - Simultaneous Spinal Cord/Brain fMRI
Stanford Medicine Stanford University: The Systems Neuroscience and Pain Laboratory at Stanford University is currently accepting applications for a postdoctoral fellow for neuroimaging research in chronic pain. Funded by NIH (co-PIs Sean Mackey, Gary Glover), this project's overall goal is to characterize pain mechanisms in humans and to develop objective biomarkers of chronic pain. We will be specifically characterizing central sensitization and descending modulation utilizing novel simultaneous neuroimaging technology for spinal cord, brainstem, and brain. The successful candidate will have unique opportunity to engage in simultaneous spinal cord/brain fMRI and to advance spinal cord fMRI acquisition/analysis and biomarker development. Research plans include:1. Study of functional connectivity between spinal cord and brain. 2. Characterization of corticospinal pain signature. 3. Physiological noise modeling in spinal cord. 4. Refinement of multiecho spinal cord acquisition and analysis pipeline.
Application Due Date (s): Ongoing
Amount Available: The postdoctoral fellow will be responsible for designing experiments, conducting ongoing imaging, analyzing neuroimaging data, planning future studies, searching literature, and writing for publication. The fellow will have opportunity to work within a large group of interdisciplinary Stanford researchers involved with multiple studies ongoing of chronic pain.
Eligibility: Applicants should hold a PhD and experience conducting fMRI studies and analysis. Previous experience in spinal cord imaging research is an advantage.
Keywords: Biological Markers & Sensor Mechanisms, Brain, Chronic Pain, Neurology, Spinal Cord Injury
* * * * *
Postdoctoral Fellowships in Interdisciplinary Research Training in Pain/Substance Use Disorders
The Stanford Division of Pain Medicine Training Program in Pain and/or Substance Use Disorders is intended to develop postdoctoral trainees' skills to become independent investigators in the fields of pain, substance abuse disorders, and their intersection. The training program incorporates required and elective coursework, mentored research experiences, an individual integrated research project, seminars, and exposure to professional development skills, including grant proposal and manuscript writing. The aim of this program is to develop the next generation of academic leaders in pain and substance abuse disorder to ultimately can better characterize these important conditions and translate discoveries into safe and effective treatments. The postdoctoral fellow may work with one of 17 primary mentors, spanning 7 departments - Anesthesiology, Neurobiology, Medicine, Psychiatry, Biology, Radiology, and Psychology. Disciplines in which the division offers training include: Molecular and cellular biology, Optogenetics, Electrophysiology, Glia, "Omics" (genomics, proteomics, metabolomics), Neuroimaging, Cognitive neurosciences, Psychology, Clinical trials, Pharmacology, Outcomes, Health Policy and Economics. The T32 also provides tuition support to obtain Stanford Masters in Epidemiology and Clinical Research for those who would benefit from additional training in clinical research. Sponsoring Dept: Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford Medicine, Stanford University
Application Due Date (s): Ongoing
Amount Available: The positions are for 1-3 years.
Eligibility: To be appointed to a research training grant, an individual must be a citizen, a non-citizen national of the United States or must have been lawfully admitted for permanent residence (i.e., in possession of a current, valid Alien Registration Receipt Card I-551, or must be in possession of other legal verification of such status) and not be supported by any other NIH grant at the time of the T32 appointment. Individuals on temporary or student visas are not eligible. Trainees must have received, as of the beginning date of the appointment, an MD/PhD, MD or PhD or comparable doctoral degree from an accredited domestic or foreign institution. Written certification by an authorized official of the degree-granting institution that all degree requirements have been met, prior to the date training is to begin, is acceptable. Applications are encouraged from members of under-represented minority groups. Stanford is a non-discriminatory/affirmative action equal opportunity employer.
Keywords: Pain, Substance Abuse, Substance Abuse Treatment
* * * * *
Postdoctoral Fellowship Research Positions in Transcranial Magnetic Stimulation in Pain Research
The Systems Neuroscience and Pain Laboratory at Stanford University is currently accepting applications for a postdoctoral research fellow to advance Transcranial Magnetic Stimulation (TMS) in chronic pain. The lab uses state of the art technologies, including TMS, fMRI, and structural MRI, and has had a growing focus in machine learning techniques applied to neuroimaging, psychophysics and genetics. The primary role will be to advance the use of TMS to understand and treat pain. Additionally, the candidate will have the opportunity to interact with a large and growing group of interdisciplinary Stanford researchers involved with multiple studies involving acute and chronic pain including: real-time fMRI control of brain activity, spinal cord fMRI, pharmacologic fMRI, individual difference in pain and cognitive/affective dimensions of pain. The postdoctoral fellow will be responsible for conducting ongoing TMS projects, analyzing neuroimaging data, as well as planning and conducting future studies. Duties will also include manuscript preparation and management of research assistants. The most successful applicants will have a demonstrated interest in pursuing publication and grant opportunities. Facilities include multiple research-dedicated 3T MR scanners and a 7T full-bore MR scanner, as well as near-infrared spectroscopy and transcranial magnetic stimulation. Sponsoring Agency: Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford Medicine, Stanford University.
Application Due Date (s): Ongoing
Amount Available: Salary is commensurate with experience.
Eligibility: Applicants should have (or anticipate having) a Ph.D. and research background in Cognitive Neuroscience, Neurophysiology, Neuropsychology, or related fields. MD or other graduate-level applicants are also encouraged to apply and should have applicable research experience. Individuals with backgrounds in Electrical Engineering, Physics, Mathematics, Computer Science or similar fields and a strong interest/background in human neuroimaging are also encouraged to apply. <br/><br/>Applicants should be experienced at conducting TMS studies, and additional experience with neuroimaging (MRI, fMRI) is preferred. Some experience with software packages such as SPM, FSL, AFNI, and Matlab is preferred. Experience with presentation software (such as E-Prime) and other programming languages such as C a plus, but not a requirement. Applicants should also possess strong interpersonal skills and be able to work independently with minimal supervision.
Keywords: Chronic Pain Neural Stimulation Neuroimaging Neuroscience
School of Medicine - Geriatric Psychiatry Fellowship Program
The Geriatric Psychiatry Fellowship Program at the VA San Diego Healthcare System (VASDHS) and the University of California, San Diego (UCSD) is a one-year, ACGME accredited PGY-V fellowship intended for psychiatrists who wish to pursue advanced training in the mental healthcare of older adults with psychiatric and neurodegenerative illnesses and the science and policy of aging in an interprofessional setting. The program also supports and encourages fellows in research and scholarly activity. Fellows are eligible for ABPN Board Certification in Geriatric Psychiatry upon graduation. More information on Geriatric Psychiatry Fellowship Program.
Deadline: Continuous, you can apply for this opportunity at any time.
Amount: Annual Compensation $68,488 + $6,000 Housing Stipend
Eligibility: Applicants must be eligible for licensure by State of California and hold a valid California Medical License by July 1 of their fellowship year. See website for more information..
Keywords: Behavioral Medicine, Elderly Patients, Geriatric Mental Health, Hospice & Palliative Care, Psychiatry, Psychology of Aging
T32 Precision Lifestyle Medicine and Translation Research
PREMIER Postdoctoral Training Program
The program objective is to provide postdoctoral fellows who aspire to be both independent investigators and team scientists in lifestyle medicine the opportunity to develop expertise in translational research for the prevention and control of cardiovascular and respiratory chronic conditions. Fellows can focus their research and skill developments in behavioral sciences for multimorbidity prevention and control and either of the other two thematic cores of this training program: 1. Precision Lifestyle Medicine, 2. Translation Research. Postdoctoral fellows will devote at least 75% effort to mentored research, supplemented by conferences, seminars, and coursework based on individual needs. Each trainee will develop an individual development plan, and progress is to be continuously monitored and formally evaluated.
Deadline: Oct 15, 2021 (Application Deadline)
Eligibility: U.S. citizen or permanent resident, Not already received 2 years of post-doc funding from NIH training grants, PhD and/or MD or equivalent by start of training
Keywords: Applied Sciences, Behavioral Biology, Behavioral Problems or Disorders, Cardiovascular Disease, Clinical Research or Studies, Health Care Planning or PolicyInjury Prevention, Public Health, Respiratory Diseases, Social or Behavioral Science Planning or Policy
Pain and Associated Symptoms Research Fellowships
College of Nursing
The Pain and Associated Symptoms T32 provides pre- and post-doctoral research training to prepare a cadre of nurse scholars to conduct nursing research. Pain and associated symptoms research addresses a critically important emphasis of nursing science advancement that impacts the quality of life and quality of end of life care for individuals across the lifespan, from infants to older adults experiencing a wide range of conditions. The focus of the 5-year renewal period (2016-2021) will be to prepare nurses to conduct research on pain and associated symptoms, supported by best practices for use of health information technology (HIT) and translating pain research.
Deadline: 15 Nov 2021*, 01 Mar 2022* (Applications) - *Anticipated, this call is repeated once a year.
Eligibility: As specified by NIH, trainees must be U.S. citizens or non-citizen nationals or have lawfully been admitted for permanent residence at the time of appointment.
Keywords: Chronic Pain, Hospice & Palliative Care, Nursing, Pain, Patient Care Planning
Department of Psychiatry and Behavioral Sciences Fellowships
Fellowship in Addiction Psychiatry
Fellows will participate in didactic seminars relating to an integrated biopsychosocial model of substance abuse, clinical research and bioethics, journal club, and one-on-one supervision of clinical cases. Fellows will have supervised clinical responsibilities on adult and adolescent substance abuse specialty units, inpatient detoxification, dual diagnosis and maternal addiction programs, outpatient programs, and consultation-liaison services.
Residency Training Program in Child & Adolescent Psychiatry
The Child & Adolescent Psychiatry Residency Program at the University of Miami/Jackson Memorial Medical Center is an accredited two-year program that offers trainees the opportunity to participate in assessment and treatment of children and adolescents with a wide range of psychiatric disorders.
Fellowship in Forensic Psychiatry
The Fellowship in Forensic Psychiatry is a 12-month program as defined by the American Board of Psychiatry and Neurology for Certification in Forensic Psychiatry. By the start of the fellowship the candidate must have graduated from a general psychiatry program accredited by the Accreditation Council for Graduate Medical Education and be eligible for board certification in psychiatry by the American Board of Psychiatry and Neurology. Goals and objectives of the Fellowship Program in Forensic Psychiatry are to prepare the fellow to serve as a psychiatric expert in a variety of roles in the legal system. This will be evidenced by evaluations and proficiency in work in psychiatric, correctional, and legal settings.
Fellowship in Geriatric Psychiatry
By means individual supervision, small group seminars, didactic lectures, and case conferences related to clinical material and basic sciences, the sponsor provides a comprehensive training program for geriatric psychiatry.
Fellowship in Consultation-Liaison Psychiatry
The fellows are offered specialized consultation and liaison activities to provide care in the critical care setting, inpatient medical, obstetrical and surgical wards, rehabilitation units, and also at the Ryder Trauma Center at Jackson Memorial Hospital. The fellows will also have an opportunity to work in psycho-oncology and/or HIV specialty ambulatory care settings. Areas of specialized training include psycho-oncology, HIV, transplant psychiatry, cardiovascular medicine, and perinatal psychiatry.
Deadline: You can apply for this opportunity at any time.
Keywords: Addictions, Child Psychiatry, Forensic Sciences, Geriatric Mental Health, Mental Disorders, Psychiatry, Substance Abuse
Post Doctoral Research Associate-Collaborative on Health Reform and Independent Living
CHRIL Program
The primary goal of this fellowship program is to provide a highly personalized 18-month research training experience to scholars who hold doctorates or similar advanced degrees, and are personally committed to understanding and improving health policies and services for all Americans with disabilities. The fellowship will complement and extend the work of the Collaborative on Health Reform and Independent Living (CHRIL), a multisite Disability and Rehabilitation Research Project funded by the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR).
Important Dates (s): You can apply for this opportunity at any time. Review of completed applications will begin on July 15, 2021, and will continue until positions are filled.
Amount: $76,500USD, Up to 3 full time positions available. The annual salary is $51,000. This is a temporary position expected to end after 18 months. Renewal is dependent on eligibility of extension, the need for extension and/or if additional funding is secured to extend employment.
Eligibility: An earned PhD or other terminal degree in an appropriate field (e.g. MD, DPT, OD, JD, DNP, DSW, DPH, PsyD) in the past 5 years.
Keywords: Biomedical Research Training, Developmental Disabilities, Health Care Planning or Policy, Intellectual Disabilities, People with Disabilities
Yale University School of Medicine
Psychology Predoctoral Internship and Post-Graduate Fellowship
The Yale Child Study Center (YCSC) Psychology Fellowship consists of a two-year integrated training sequence: an American Psychological Association (APA) accredited internship and a (non-accredited) postgraduate Fellowship in clinical psychology.
Internship Year: Interns receive extensive training in the psychological and neuropsychological assessment of children, and therapeutic interventions that embrace multiple theoretical perspectives, including developmental, psychodynamic, cognitive-behavioral, and family systems theory. Opportunities are available to conduct clinical research at the Yale Child Study Center, and to teach on clinically related topics in child psychology.
Fellowship year: All interns remain with the Psychology Training program for a second year. Approximately 50% of the training focuses on hospital-based evaluation and treatment of children with serious psychiatric illness. Second year fellows work as primary clinicians on a child or adolescent psychiatry inpatient unit and consult to the pediatric emergency department. The remaining 50% of training is dedicated to the area of focus initiated during the internship year. Continued clinical intervention with children and families, along with opportunities for involvement in ongoing research projects, is highlighted in the focused training area.
Deadline: 01 Nov 2021 (Application) Anticipated, this call is repeated once a year.
Amount: Postdoctoral associates are paid $50,629 for a full year; this amount is prorated if doctoral degree requirements are met after July 1 of the second year.
Eligibility: Graduate Student or Pre-doc. Doctoral candidates enrolled in APA Accredited programs in Clinical, Counseling, or School Psychology may apply.
Keywords: Autism Child, Psychiatry, Child Psychology, Developmental Disabilities, Disease, Early Childhood Development, Health of Underserved Populations, Medical Intervention Agents, Neuropsychology, Pediatrics, Traumatology, Accidents & Injury
The Neuroimaging Sciences Training Program (NISTP) in Addiction trains scientists in technological aspects of data acquisition and analysis, clinical and biological fundamentals in areas of interest to each trainee as related to substance abuse and dependence, development of research proposals, and generation of documentation to navigate today's administrative requirements for imaging research. The program is designed to last 2-3 years, and the purposes of the program are the following: Provide formal course training to postdoctoral fellows, with an emphasis on imaging and clinical research methodology, and instruction in their underlying multidisciplinary sciences. Provide mentored training for fellows to apply these new methods to the interdisciplinary advance of our understanding of the function of the brain in substance use disorders. Provide an integrated research experience for fellows in both imaging applications and methodology. All fellows will be expected to complete at least one research project with an applications and one with a methodology mentor during their training period. Each fellow will work on two projects: one focused on methodology and one focused on an application in substance use. There will be two mentors, one for each of the projects, and it is the fellow's choice which will be the primary mentor and associated area of work.
Application Due Date (s): Ongoing
Amount Available: not specified
Eligibility: Applicants must have U.S. citizenship or permanent resident status.
Keywords: Addictions, Brain, Data Management or Analysis (Medical), Neuroimaging, Substance Abuse
Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry
The Agnes Purcell McGavin Award for Distinguished Career Achievement, established in 2000, is presented to a child and adolescent psychiatrist who has been noted for outstanding contributions to the advancement of child and adolescent psychiatry in activities such as teaching, research, writing, clinical care, advocacy, and policy. Funded by a bequest from Dr. Agnes Purcell McGavin.
Deadline: 15 Aug 2022 (Nomination) Anticipated, This call is repeated once a year.
Amount: A plaque and $1,500 will be presented at an appropriate child and adolescent psychiatry session during APA's Annual Meeting.
Eligibility: A child/adolescent psychiatrist. Previous winners of the McGavin Award for Prevention are eligible
Keywords: Child or Adolescent Mental Health, Child Psychiatry, Psychiatry
* * * * *
Ittleson Award
The Blanche F. Ittleson Award — established in 1976 in memory of noted philanthropic friend of psychiatry Blanche F. Ittleson — recognizes outstanding and published research in child and adolescent psychiatry that has resulted in, or promises to lead to, a significant advance in promoting the mental health of children. This award is funded by a grant from the Ittleson Foundation.
Deadline: 30 Sep 2021(Nomination) - This call is repeated once a year.
Amount: The $2,000 and a plaque will be presented at the Early Research Career Breakfast held during APA's Annual Meeting in May.
Eligibility: A psychiatrist or a group of psychiatric investigators are eligible.
Keywords: Child or Adolescent Mental Health, Child Psychiatry, Psychiatry
* * * * *
Research Colloquium for Junior Investigators
The Research Colloquium for Junior Psychiatrists is presented by APA in conjunction with the APA Council on Research's Workgroup on Research Training. The event includes a two-day, immersive, research experience for junior psychiatrists in the beginner-level (Track 1) and intermediate-level (Track 2) of their research training in psychiatry. It is an important opportunity for mentorship, guidance, information on research career development and grantsmanship, and networking with senior research mentors in psychiatry (i.e., Drs. Charles Nemeroff, Kerry Ressler, Anissa Abi-Dargham, and Wilson Compton) and from the sponsoring organizations. Candidates whose research interests are similar to those listed below are encouraged to apply. Potential candidates with research interests in health disparities and substance use, and those from underrepresented and minority groups are strongly encouraged to apply.
The two-day workshop will focus on the following five research areas:
Molecular, Translational, and Neuroscience Research
Clinical Psychobiology
Treatment from Psychopharmacology and Psychotherapy to Neural Strategies
Alcohol, Pain, and Drug Abuse Research
Health Disparities and Health Services Research
Deadline: 21 Dec 2021 (Application) - This call is repeated once a year.
Amount: A $1,200 stipend will be provided to partially cover travel expenses.
Eligibility: Beginner- or intermediate-level early research career psychiatrist investigators who are residents, fellows, or junior faculty.
Keywords: Alcohol or Alcoholism, Clinical Research or Studies, Drugs or Drug Abuse, Health Disparities, Health Services Delivery, Neuroscience, Pain, Psychiatry, Psychobiology, Psychopharmacology, Psychotherapy, Substance Abuse
American Psychosomatic Society Awards
The mission of American Psychosomatic Society (APS) is to advance and integrate the scientific study of biological, psychological, behavioral and social factors in health and disease.
ASSC William James Prize
The William James Prize is awarded for the most outstanding single published contribution to the empirical or philosophical study of consciousness. The prize will be given for Theoretical and Empirical work in alternate years. Theoretical contributions include philosophical and theoretical/computational submissions, whereas Empirical contributions should report analyses of original data and encompass behavioural, neural and/or clinical submissions. The 2020 Prize was awarded for Theoretical contributions.
Deadline: 31 Jan 2022 (Application) - Anticipated, this call is repeated once a year.
Amount Available: The prize consists of:
An award of $1,500(USD),
An invitation to present a plenary address at ASSC24, held in June 2020 in Tel Aviv, Israel (travel, accommodation, and registration paid by ASSC).
A lifetime membership in ASSC.
Eligibility: The nominee must be a graduate student or postdoctoral scholar/researcher who obtained a PhD or other advanced degree within six years of the submission deadline (i.e - Graduated between 2014 - 2020).
Keywords: Arts and Humanities, Belief or Knowledge Systems, Cognitive Science, General Humanities Topics, General Science and Technology Topics, Health and Medicine, Human Learning and Memory, Natural and Physical Sciences, Mathematics and Technology, Neuroscience, Philosophy, Philosophy of Science, Psychodynamic, Psychology, Social Sciences
Undergraduate Scholars Program at the Janelia Research Campus, Virginia
The Janelia Undergraduate Scholars program is a summer program aimed at well-prepared, independent, and committed students with significant research experience. We accept undergraduates and masters students from around the world who have not committed to a PhD program. Participants must be actively enrolled as a student during the period of the Janelia Undergraduate Scholars program. This program provides an outstanding research experience, an opportunity to network with colleagues at all career levels, and a chance to form lifelong scientific collaborations and friendships. Janelia undergraduate scholars are dedicated future scientists, engineers, and mathematicians who are interested in exploring:
Deadline: 11 Jan 2022 (Application) - Anticipated, this call is repeated once a year.
Amount Available: $5,000USD. The Undergraduate Scholars Program runs from May to August. Students are required to spend a full 10 weeks at Janelia, but we are flexible on the specific start and end dates to accommodate differing academic calendars at universities. All Janelia undergraduate scholars live together on campus. All living expenses including housing, food, and travel to and from Janelia are covered by the program. Students also receive a stipend of $5,000 for the 10-week period.
Eligibility: Applicants must have at least one independent research experience that is not part of a course.
Actively enrolled undergraduate students or masters students who have not yet committed to a PhD program are eligible to apply. Students should have programming experience in at least one of the following languages: Python, MATLAB, and/or C++. Other languages may also be suitable. International students are eligible and visas will be supported.
Keywords: Biochemistry & Molecular Biology, Cell & Developmental Biology, Computational Neuroscience, Evolution, Genetics, Molecular Cellular Entities, Neurons, Neuroscience, Optics, Scientific Apparatus & Instruments, Structural Biology
*Anticipated* Application Due Date (s): October 15, 2021
Sponsoring Agency: SHAPE America (Society of Health and Physical Educators)
Amount Available: Not specified
Abstract: The purpose of this scholarship is to assist graduate students focusing on psychomotor measurement and evaluation in paying their professional expenses.The recipient must demonstrate potential for succeeding in both the degree program and as a professional in psychomotor measurement and evaluation.
Eligibility: The recipient shall:Be a current member of SHAPE America and the Measurement and Evaluation be presently a masters or doctoral student pursuing studies focusing on psychomotor measurement and evaluation at a college or university in the United States; have at least one more academic year of training after receiving the scholarship. Priority will be given to candidates who have completed the first year of their degree program.
Funding Website:
SHAPE Grad. Award
Keywords: Developmental Disabilities, Intellectual Disabilities, Quantitative Psychology, Social or Recreation Services for People with Disabilities
Norwegian Academy of Science and Letters Kavli Prize
The Kavli Prize is a partnership between The Norwegian Academy of Science and Letters, The Kavli Foundation (United States), and The Norwegian Ministry of Education and Research. The Kavli Prizes recognize scientists for pioneering advances in our understanding of existence at its biggest, smallest, and most complex scales. The Kavli Prizes recognize seminal scientific achievements in Astrophysics,
Neuroscience and Nanoscience as follows:
Psychometric Society Dissertation Prize
The Psychometric Society Dissertation Prize recognizes at most one outstanding Ph.D. dissertation each year, written in any field covered by the journal Psychometrika. Criteria include the originality and rigor of the research, possible applications of the theory or methods and potential impact.
Application Due Date (s): October 31, 2021
Amount Available: See funding website
Keywords: Analytical Psychology, Applied Psychology, Behavioral or Experimental Psychology, Clinical Psychology, Cognitive Psychology, Comparative Psychology, Developmental Psychology, Educational Research, Experimental Psychology, Quantitative Psychology, Science Journalism
*Anticipated* Application Due Date (s): February 1, 2022
Sponsoring Agency: Educational Testing Service (ETS)
Amount Available: $7,500
Abstract: If you are a creative and innovative individual who wants to help shape the future of learning and assessment, we encourage you to apply for the 2021 Summer Research and Measurement Sciences (RMS) Internship program. Steeped in decades of broad expertise, RMS conducts rigorous foundational and applied research on the most critical issues facing education and the workforce. Central to ETS’s legacy of global leadership in learning and assessment, RMS is dedicated to advancing the science and practice of measurement, driving innovation in digital assessment, learning and teaching. Interns who are accepted into the program will collaborate with scientists on projects related to these topics and will participate in data analysis, writing and other research tasks. Doctoral students who have completed at least two years in one of these or a related field are encouraged to apply. Upon the completion of the program, you’ll have the opportunity to present your findings to teams across.
Eligibility: Current full-time enrollment in a relevant doctoral program. Completion of at least two years of coursework toward the doctorate prior to the program start date.
Funding Website:
summer-rms-intership
Keywords: Career Education and Planning, Educational Evaluation, Educational Research, Educational Tests & Measurements, Human Learning and Memory, Instructional Technology, Linguistics or Philology, Quantitative Psychology, Statistics, Technology Education
*Anticipated* Application Due Date (s): April 22, 2022
Sponsoring Agency: American College of Neuropsychopharmacology (ACNP)
Amount Available: See sponsor's website.
Abstract: The American College of Neuropsychopharmacology (ACNP) annually selects distinguished young scientists in the field of neuropsychopharmacology to be part of our travel award program. Any scientist worldwide is eligible to apply for a travel award. All candidates must be eligible in one of the three applicant tiers AND meet training/post training limits. Candidates from underrepresented populations in science and medicine are highly encouraged to apply. Please note, ACNP members (all categories of membership) and previous Travel Awardees are not eligible to apply.
Funding Website:
Annual Meeting Travel Award
Keywords: Adverse Effects, Behavioral Pharmacology, Neuropharmacology, Neuropsychopharmacology, Psychopharmacology
Application Due Date (s): June 14, 2022 (Conference Proposals)
Sponsoring Agency: National Science Foundation (NSF) Division of Behavioral and Cognitive Sciences
Amount Available: $2,000
Abstract: The PAC program funds theoretically motivated research on a wide-range of topic areas focused on typical human behavior. The aim is to enhance the fundamental understanding of perceptual, motor, and cognitive processes and their interactions. Central research topics for consideration by the program include vision, audition, haptics, attention, memory, reasoning, written and spoken language, and motor control. The program welcomes a wide range of perspectives, such as individual differences, symbolic computation, connectionism, ecological, genetics, nonlinear dynamics, and complex systems, and a variety of methodologies including both experimental studies and modeling. The PAC program is open to co-review of proposals submitted to other programs both within the Social, Behavioral, and Economic Sciences Directorate and across other directorates. Proposals may involve clinical populations, animals, brain imaging, or computational modeling, or factors such as emotion and sleep, only if the work has direct impact on our understanding of basic processes underlying human perception, action, or cognition.
Funding Website:
Keywords: Audiology, Balance (physical), Cognitive Development or Processes, Ears & Hearing, Human Learning and Memory, Sensory Integration Disorders, Sensory Physiology, Sensory System, Vision
*Anticipated* Application Due Date (s): June 18, 2022
Sponsoring Agency: Bryon Riesch Paralysis Foundation
Amount Available: $2000 - $4000
Abstract: Priority going to direct spinal cord injuries and diseases resulting in paralysis such as spinal tumors, strokes or aneurysms affecting the spinal cord, or spina bifida. Other diseases and disorders that would be considered include MS, traumatic brain injuries, Parkinson's and cerebral palsy.
Eligibility: Individuals: Undergraduate Student Persons with Disabilities only
Funding Website:
BRPF Scholarship
Keywords: Cerebral Palsy, Higher Education, Multiple Sclerosis, Paralysis, Parkinsons Disease, Spinal Cord Diseases, Spinal Cord Injury, Undergraduate Education
*Anticipated* Annual Application Due Date (s): June 24, 2024
Sponsoring Agency: American College of Neuropsychopharmacology (ACNP)
Abstract: The American College of Neuropsychopharmacology (ACNP) presents NINE awards during its annual meeting. Awards consists of a monetary award and a plaque to be given during the Annual Meeting. The award winner must attend the Annual Meeting. See website for more information.
Paul Hoch Distinguished Service Award - The ACNP presents this award when a member has made unusually significant contributions to the College. The emphasis of this award is on service to the College;not for teaching, clinical, or research accomplishment.
Julius Axelrod Mentorship Award - The ACNP presents this award to an ACNP member who has made an outstanding contribution to neuropsychopharmacology by mentoring and developing young scientists into leaders in the field.
Eva King Killam Research Award - The ACNP presents this award to an early career researcher on the basis of outstanding translational research contributions to neuropsychopharmacology. The nominee's research should contribute to translating between basic science and human investigations. The selection of the awardee is based on the quality of the contribution and its impact in advancing neuropsychopharmacology.
ACNP Media Award- The ACNP Media Award was established to recognize major contributions to the education of the public about mental illness and substance abuse research and the positive impact of research on treatment.
Daniel H. Efron Research Award - The ACNP presents this award to an individual on the basis of outstanding basic research contributions to neuropsychopharmacology. The selection of the awardee is based on the quality of the contributions and their impact in advancing neuropsychopharmacology.
Funding Website:
ACNP Honorific Awards
Application Due Date (s): Ongoing - quarterly: March, June, September, and December.
Sponsoring Agency: Project Athena Foundation
Amount Available: see website:
Abstract: The Project Athena Foundation is a 501c3 non-profit foundation dedicated to helping survivors of medical or other traumatic setbacks achieve their adventurous dreams. At Project Athena, we provide travel expenses, coaching, equipment, and most importantly, the encouragement and inspiration needed to help these strong, amazing women make that life-affirming transition from Survivor to Athlete. We currently offer four yearly adventures that provide mental and physical challenges in a non-competitive environment. At Project Athena, we believe it’s all about teamwork and being a part of the family. Apply today to join us as an Athena, if you are a survivor of a medical setback, OR register for an event as a Fundraising God or Goddess to show your support for a great cause!
Applicant Type: Individuals: Early Career and Emerging in Field Individuals: Graduate Student or Pre-doc Individuals: Mid-Career to Established in Field Individuals: Undergraduate Student
Funding Website:
Athena Grant
Keywords: Cancer or Carcinogenesis, Chronic Illnesses, Exercise, Posttraumatic Stress Disorder, Trauma and Emergency Surgery, Traumatic Brain Injury, Traumatology, Accidents & Injury, Women's Health